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Experimental evidence suggests that nitric oxide (NO) and hydro-
gen sulfide (H2S) signaling pathways are intimately intertwined,
with mutual attenuation or potentiation of biological responses in
the cardiovascular system and elsewhere. The chemical basis of
this interaction is elusive. Moreover, polysulfides recently emerged
as potential mediators of H2S/sulfide signaling, but their biosynthesis
and relationship to NO remain enigmatic. We sought to characterize
the nature, chemical biology, and bioactivity of key reaction products
formed in the NO/sulfide system. At physiological pH, we find that
NO and sulfide form a network of cascading chemical reactions that
generate radical intermediates as well as anionic and uncharged sol-
utes, with accumulation of three major products: nitrosopersulfide
(SSNO−), polysulfides, and dinitrososulfite [N-nitrosohydroxylamine-
N-sulfonate (SULFI/NO)], each with a distinct chemical biology and in
vitro and in vivo bioactivity. SSNO− is resistant to thiols and cyanol-
ysis, efficiently donates both sulfane sulfur and NO, and potently
lowers blood pressure. Polysulfides are both intermediates and prod-
ucts of SSNO− synthesis/decomposition, and they also decrease blood
pressure and enhance arterial compliance. SULFI/NO is a weak com-
bined NO/nitroxyl donor that releases mainly N2O on decomposition;
although it affects blood pressure only mildly, it markedly increases
cardiac contractility, and formation of its precursor sulfite likely con-
tributes to NO scavenging. Our results unveil an unexpectedly rich
network of coupled chemical reactions between NO and H2S/sulfide,
suggesting that the bioactivity of either transmitter is governed by
concomitant formation of polysulfides and anionic S/N-hybrid species.
This conceptual framework would seem to offer ample opportunities
for the modulation of fundamental biological processes governed by
redox switching and sulfur trafficking.
sulfide | nitric oxide | nitroxyl | redox | gasotransmitter
Nitrogen and sulfur are essential for all known forms of lifeon Earth. Our planet’s earliest atmosphere is likely to have
contained only traces of O2 but rather large amounts of hydrogen
sulfide (H2S) (1). Indeed, sulfide may have supported life long
before the emergence of O2 and NO (2, 3).* This notion is
consistent with a number of observations: H2S is essential for
efficient abiotic amino acid generation as evidenced by the
recent reanalysis of samples of Stanley Miller’s original spark
discharge experiments (4), sulfide is an efficient reductant in
protometabolic reactions forming RNA, protein, and lipid pre-
cursors (5), and sulfide is both a bacterial and mitochondrial sub-
strate (6), enabling even multicellular lifeforms to exist and
reproduce under conditions of permanent anoxia (7). Thus, although
eukaryotic cells may have originated from the symbiosis of sulfur-
reducing and -oxidizing lifeforms within a self-contained sulfur
redox metabolome (8), sulfide may have been essential even
earlier by providing the basic building blocks of life.
The chemical reactions of sulfur-centered nucleophiles with a
range of nitrogen-containing species have been studied for dif-
ferent reasons and as independent processes for more than a
century, and early reports indicated complex reaction mecha-
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nisms (9–13). The recent surge of interest in this chemistry in
the biological community (13–15) was triggered by a growing
appreciation that NO and sulfide exert similar and often in-
terdependent biological actions within the cardiovascular system
and elsewhere (NO/H2S “cross-talk”) (16, 17), resulting in mu-
tual attenuation or potentiation of their responses. This cross-
talk is possibly mediated by chemical interactions (18–20), but
much of the older chemical work seems to have been forgotten.
Recently, low concentrations of sulfide were shown to quench
NO-mediated vascular responses through formation of an unchar-
acterized “nitrosothiol” (RSNO) (18–20), assumed to be thionitrous
acid (HSNO) (13–15).
A recent report of the detection by MS of the highly unstable
HSNO at physiological pH (21) has attracted considerable at-
tention from the biological community, because it could be an
intermediate in the reaction of sulfide with RSNOs (22) and a
precursor for NO, nitrosonium (NO+) equivalents, and nitroxyl
(HNO). However, a key aspect of HSNO’s properties that seems
to have been overlooked in these discussions is its mobile hy-
drogen, allowing facile 1,3 hydrogen shift and formation of four
isomers with the same chemical equation (13)—a feature de-
scribed in the seminal studies by Goehring in the 1950s (23) and
by Müller and Nonella later on (24, 25) that distinguishes HSNO
from all other RSNOs (26). The same feature also contributes
to the short half-life of the molecule at ambient temperatures,
making it more probable that other yet unknown entities are in-
volved as biological mediators of the NO/H2S cross-talk. Chemical
studies by Seel and Wagner (9, 10) showed that NO readily reacts
with HS− in basic aqueous solution or organic solvents under
anoxic conditions to form the yellow nitrosopersulfide (SSNO−).
Accumulation of this product was also observed after reaction
of RSNOs with sulfide at pH 7.4 (26, 27); moreover, SSNO−-
containing mixtures were found to release NO, activate soluble
guanylyl cyclase (sGC) (26), and relax vascular tissue (28), although
a contribution of other reaction products to these effects cannot
be excluded. Meanwhile, other sulfane sulfur molecules, including
persulfides (RSSH) and polysulfides (RSSn
− and HSn
−), have
come to the fore as potential mediators of sulfide’s biological
effects (29–31), but little is known about their pathways of forma-
tion, prevalence in biological systems, and relationship with NO.
In view of this confusion, we sought to carry out an integrative
chemical/pharmacological investigation to study the chemical bi-
ology of the reaction of NO with sulfide more thoroughly and sys-
tematically identify potentially bioactive reaction products. We here
report that the NO/H2S interaction leads to formation of at least
three product classes with distinct in vivo bioactivity profiles:
nitrosopersulfide (SSNO−), polysulfides (HSn
−), and dinitrososulfite
[ONN(OH)SO3
− or N-nitrosohydroxylamine-N-sulfonate (SULFI/
NO)]; all anions at physiological pH. Their formation is accompa-
nied by both scavenging and release of NO and H2S and formation
of nitrous oxide (N2O), nitroxyl (HNO), nitrite (NO2
−), nitrate
(NO3
−), and various sulfoxy species. These results not only offer an
intriguing explanation for the quenching and potentiating effects of
sulfide on NO bioavailability but also, provide a novel framework
for modulation of fundamental biological processes governed by
redox switching and sulfur trafficking. This chemistry is likely to
prevail wherever NO and sulfide are cogenerated.
Results
Sulfide Modulates NO Bioavailability in a Concentration-Dependent
Manner. Effects of sulfide on NO bioavailability and hemody-
namics were investigated in anesthetized rats. Pilot studies con-
firmed that sodium hydrosulfide (NaHS; 1.8–18 μmol/kg) lowers
blood pressure and heart rate in a dose-dependent manner; ef-
fects were short-lived and accompanied by alterations in NO
metabolite status in RBCs and plasma (SI Appendix, Fig. S1 and
Table S1). As with inhaled NO (32), higher sulfide doses in-
creased total nitroso (RXNO) levels in RBCs (SI Appendix, Fig.
S1). Inhibition of NO synthase by S-ethylisothiourea prolonged
the action of sulfide and markedly increased its toxicity (SI Ap-
pendix, Fig. S1 A and B), showing that endogenous NO production
modulates sulfide bioactivity and attesting to the reciprocal nature
of interaction of these signaling molecules. In subsequent experi-
ments, NaHS was administered by continuous infusion (2.8 μmol/kg
per minute in PBS, pH 7.4) to counter the rapid rate of sulfide
elimination (33), and blood was collected repeatedly for measure-
ment of circulating NO biomarkers (Fig. 1 and SI Appendix, Fig. S2
and Table S2). Consistent with the notion that vascular sulfide levels
rise only after inactivation (binding/elimination) pathways become
saturated, no significant hemodynamic changes were observed in the
20 min
10 mmHg
0 30 60 90 120
-20
-15
-10
-5
0
5
NaHS infusion time (min)
M
A
P
(m
m
H
g)
* *
0 30 60 90 120
-100
0
100
200
300
NaHS infusion time (min)
N
O
-H
em
e
(%
)
*
* * *
* *
*
0 30 60 90 120
-200
0
200
400
600
NaHS infusion time (min)
R
XN
O
 (%
)
* *
*
A B
C D
00
100
200
N
O
 (p
pb
)
+1X HS- (33.4 M)
+ 10X HS- (334 M)
Time (min)
10 20
DETA/NO 33.4 M
0
1
2
3
410
15
20
25
30 w/o Na2S
1 M Na2S
10 M Na2S
100 M Na2S
*
*
*
*
#
*cG
M
P 
le
ve
ls
(v
s.
 u
nt
re
at
ed
)
0
10
20
 1X HS-
DETA/NO
10X HS--
10 20
E F
aerated
deaerated
0 60 120
300
350
400
H
R
(m
in
-1
)
NaHS infusion time (min)
+IBMX + Sper/NO
+ Na2S
15 min
CTRL Sper/NO 100 M
10 min
B
P
(m
m
H
g)
2.8 µmol/kg/min
2.8 µmol/kg/min2.8 µmol/kg/min
Fig. 1. Sulfide affects NO bioavailability in vivo and in vitro. (A and B)
Continuous i.v. infusion of sodium hydrosulfide (2.8 μmol/kg per min NaHS in
PBS, pH 7.4) progressively decreases blood pressure (BP) in rats. (A) Original
recording depicting progressive decrease in BP during ongoing sulfide in-
fusion; incisions (arrows) are caused by interruption of pressure recording
during blood collection. (B) Changes in mean arterial blood pressure (MAP;
n = 5; ANOVA P = 0.0256) and (Inset) heart rate (HR). *Dunnett’s P < 0.05 vs.
baseline. (C) Gradual increases in circulating nitroso species (RXNO) levels in
RBCs (n = 3; ANOVA P = 0.0032). *Dunnett’s P < 0.05 vs. baseline. (D) Con-
comitant transient decrease followed by an increase in NO-heme levels
during continuous sulfide infusion (2.8 μmol/kg per min NaHS in PBS, pH 7.4;
n = 3; ANOVA P = 0.0126). *Tuckey P < 0.05 vs. baseline. (E) Sulfide (10 μM
Na2S) decreases Sper/NO (100 μM)-mediated sGC activation in RFL-6 cells
pretreated with the phosophdiesterase inhibitor 3-isobutyl-1-metylxanthine
(IBMX). The scheme represents the experimental setup (n = 6; ANOVA P <
0.001). CTRL, control. *Tuckey P < 0.01 vs. untreated. # t test P < 0.05 (F)
Equimolar concentrations of sulfide (33.4 μM) scavenge NO released form
NO donors (33.4 μM DETA/NO) as assessed by time-resolved chemilumines-
cence detection under both aerated and (Inset) deaerated conditions, whereas
excess sulfide (334 μM) transiently elevates NO release (representative of n = 3
independent experiments); DETA/NO, diethylenetriamine NONOate.
E4652 | www.pnas.org/cgi/doi/10.1073/pnas.1509277112 Cortese-Krott et al.
first 30 min of infusion (Fig. 1 A and B and SI Appendix, Table S2),
albeit NO-heme levels dropped significantly (Fig. 1D). After 1 h of
sulfide infusion, blood pressure was significantly lower, whereas
heart rate remained constant (Fig. 1 A and B and SI Appendix,
Table S2). The lack of a compensatory rise in heart rate and the
decrease in respiratory rate that accompanied the fall in mean
arterial pressure are consistent with the recognized metabolic
effects of sulfide, capable of inducing a state of suspended ani-
mation (34). Concomitant with these changes in blood pressure,
erythrocyte RXNO and NO-heme levels gradually increased
(Fig. 1 C and D).
The effect of sulfide on NO-induced sGC stimulation was tested
in an NO reporter cell line in the presence of a phosphodiesterase
(PDE) inhibitor. Low sulfide concentrations (10 μM) inhibited
sGC stimulation by the NO donor, spermine NONOate (Sper/NO;
100 μM), whereas cGMP levels at equimolar concentrations of
sulfide and Sper/NO did not differ from those of Sper/NO alone
(Fig. 1E). Although constitutive cGMP–PDE activity in these cells
is very low (26) and cells were pretreated with a PDE inhibitor,
100 μM sulfide increased cGMP on its own (Fig. 1E), prohibiting
the use of higher sulfide concentrations to investigate NO re-
sponses in these cells. Additional chemical experiments with NO
donors/sulfide in cell-free buffer systems confirmed that sulfide,
dependent on concentration, either quenches or transiently en-
hances NO as detected by chemiluminescence (Fig. 1F).
Collectively, these data show a dual effect of sulfide on NO
bioavailability, with lower doses inhibiting and higher doses re-
storing (or in some cases, potentiating) NO bioactivity in cell-
free systems, cells in vitro, and rats in vivo.
Sulfide Reacts with NO to Form Polysulfides and Two NO-Containing
S/N-Hybrid Species. Our next efforts were directed toward eluci-
dating whether there is a chemical foundation for this NO/H2S
cross-talk by identifying specific reaction products. UV-visible
spectroscopy offered a first glimpse into the chemistry of the
NO/sulfide interaction. A dominant product of the reaction of
sulfide with NO (Fig. 2A), the NO donor DEA/NO (Fig. 2 B–D
and SI Appendix, Fig. S4), or RSNOs (SNAP in Fig. 2E) (other
RSNOs are in ref. 26) in aqueous buffer at pH 7.4 in both the
absence and the presence of O2 is a yellow compound (λmax = 412
nm), in particular when sulfide is in excess (Fig. 2 C and D). We
(13, 26) and others (9, 10, 27, 35) attributed this species to SSNO−.
We here extend those earlier observations with RSNOs to NO
itself (as shown by the reaction of sulfide with aqueous NO so-
lution and NO donors). Absorbance increases in the regions of
250–300 nm and below 250 nm are also apparent (Fig. 2, arrows).
The reaction products absorbing in the region around 300 nm
(λ = 290–350 nm) seem to be HSn−, because this feature dis-
appeared on addition of the classical sulfane sulfur-reducing
reagents DTT or cyanide (SI Appendix, Fig. S5 A and B) or
millimolar concentrations of cysteine and glutathione (26).
Contrary to HSn
−, the SSNO− peak was resistant toward thiols
and cyanide (SI Appendix, Fig. S5 A and B), and its decomposition
rate was hardly affected by the presence of these chemicals (SI
Appendix, Fig. S5C). Like HSn
− but contrary to classical RSNOs,
SSNO− is relatively stable at neutral and basic pH levels (SI
Appendix, Fig. S5C) but rapidly decomposes with formation of
colloidal sulfur and H2S on acidification as shown previously (26).
Interestingly, HSn
−s are not only products of SSNO− decomposition
(SI Appendix, Fig. S5D) but also, likely intermediates with clear
catalytic effects on SSNO− formation (Fig. 2F). Under conditions of
no/low added HSn
−, an induction period is observed that disappears
at higher HSn
− concentrations (Fig. 2F), pointing to possible au-
tocatalytic effects of HSn
− formed during the reaction between
sulfide and NO/RSNO. The product yield in the reaction of SNAP
with excess sulfide approached 30% for SSNO− as estimated by
measuring the concentrations of either H2S or sulfane sulfur
atoms liberated by reduction, cyanolysis, or chloroform extraction
during formation and/or decomposition of SSNO− (SI Appendix,
Fig. S5) and was calculated to be ∼34% in nonaqueous media (e =
2,800 M−1 cm−1, λmax = 448 nm) (35). Furthermore, SSNO− de-
composition in the presence of DTT released two times as much
sulfide as sulfane sulfur (SI Appendix, Fig. S5D and E). Therefore,
SSNO− contains two sulfur atoms, one of which is a sulfane sulfur.
In the reaction of NO with sulfide, in basic aqueous and
nonaqueous conditions under exclusion of air, Seel and Wagner
(9) also observed the formation of SULFI/NO ([ONN(OH)SO3]
−),
a complex formed by the reaction of sulfite with NO. This
product is also known as dinitrososulfite (36) (λmax = 259 nm,
e = 8,198 M−1 cm−1), which we find to be another product of
the reaction of NO and sulfide at physiological pH. Indeed, a
peak with λmax = 259 nm appears in RSNOs/sulfide incubates after
A B
C D
E F
Fig. 2. The reaction of NO with sulfide leads to formation of three major
products, which we assign to be SSNO− (λmax = 412 nm), HSn− (λmax = 290–
300 nm), and SULFI/NO (λmax = 259 nm). (A) Reaction of aqueous solutions of
NO (200 μM) with sulfide (2 mM) under deaerated conditions in buffer at
pH 7.4 leads to formation of a peak with λmax = 412 nm (SSNO−) and increases
in absorbance at λmax < 300 nm (HSn−). Products with λmax < 250 nm are not
discernable from sulfide because of the high concentration of HS− (λmax =
230 nm) in these experiments; spectra were taken at the reaction start (blue)
and every 5 s after the addition of NO. (Inset) kinetics of SSNO− formation.
(B) Reaction of the NO donor DEA/NO (1 mM) with sulfide (10 mM) under
aerated conditions forms SSNO− and HSn
−. The blue line indicates the spectrum
before the addition of sulfide. (Inset) Kinetics of formation of SSNO−. (C and D)
The yield of SSNO− formation depends on both (C) sulfide concentration and
(D) the rate of NO release; all spectra were taken 10 min after the start of the
reaction. (E) SSNO− (λmax = 412 nm), HSn− (λmax = 290–300 nm), and SULFI/NO
(λmax = 259 nm) are formed in the reaction of sulfide with the S-nitrosothiol
SNAP (1 mM SNAP + 10 mMNa2S; 10 min); SULFI/NO is detectable after removal
of sulfide by gassing with N2 for 10 min. (F) Addition of HSn
− (12.5–200 μM)
increases the rate of formation of SSNO− from the reaction of SNAP (200 μM)
and sulfide (2 mM); the induction period observed at no/low added HSn
− points to
an autocatalytic effect of HSn
− (n = 3). All spectra in A–E are representative of 3–10
independent experiments. Au, arbitrary unit; DEA/NO, dietylamine/NONOate;
SNAP, S-nitroso-N-acetyl-penicillamine.
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removal of excess unreacted sulfide by bubbling with N2 (Fig. 2E).
The formation of SULFI/NO from DEA/NO/sulfide mixtures
cannot be followed spectrophotometrically, because DEA/NO
(like SULFI/NO) is a diazeniumdiolate (36) that absorbs in the
same wavelength range. Other putative reaction products are sulfoxy
species, including sulfite, sulfate, thiosulfate (S2O3
2−), and poly-
thionates ([O3S-Sx-SO3]
2−), all absorbing at wavelengths <250 nm
and spectrophotometrically difficult to distinguish from each other.
Taken together, these results show that the reaction of sulfide
with NO or RSNO under physiologically relevant conditions
leads to formation of three major reaction products: SSNO−,
HSn
−, and SULFI/NO. These products have been described in
different contexts before, but we find that all three are formed in
sequential reactions of the same chemical system under physio-
logically relevant conditions. With high NO fluxes and excess
sulfide, SSNO− is a major reaction product.
Mass Spectrometric Identification of the Products of the Sulfide/NO
Reaction. To definitively identify the reaction products of NO
(1 mM DEA/NO) or RSNOs (1 mM SNAP) with sulfide (2 mM
Na2S), incubation runs in phosphate or Tris buffer at pH 7.4
were subjected to electrospray ionization (ESI)–high-resolution
MS (HRMS) analysis (Fig. 3 and SI Appendix, Table S7). Be-
cause many of the key reaction products were suspected to be
negatively charged species at pH 7.4, negative ionization mode
was used throughout. The S/N-hybrid species SSNO− (compound
1; m/z theoretical = 93.94268, m/z found = 93.9427, error = 0.39
milli mass units, mmu) and SULFI/NO (compound 2; HO5N2S
−;
m/z theoretical = 140.96061, m/z found = 140.9612, error = 0.35
mmu) and multiple polysulfide species, including HS3
−, HS4
−, and
HS5
−, were identified as reaction products of sulfide with either
NO donor (Fig. 3). For SSNO− and SULFI/NO, assigned struc-
tures were confirmed by analysis of their fragmentation pattern
(Fig. 3 A, Center and B, Center); the former was found to eliminate
NO by hemolytic cleavage, forming the persulfide radical (S2·
−)
(Fig. 3A), whereas N2O elimination and sulfate formation (de-
tected as HSO4
−) characterized the latter (Fig. 3B). The structural
assignments were unequivocally confirmed using 15N labeling,
resulting in anm/z shift of 1 for SSNO− and 2 for SULFI/NO (Fig.
3 A, Right and B, Right). Changes in relative abundance of reaction
products over time were monitored during direct infusion of the
reaction mixture into the ionization chamber. These studies
revealed that both SSNO− and SULFI/NO are formed surprisingly
quickly (≤2 s, which was evidenced by additional experiments
using NO/sulfide coinfusion by a T piece close to the ionization
source) from both NO and RSNOs followed by gradual accumu-
lation of medium-chain/long-chain HSn
−.
More in-depth analysis of reaction mixtures by ESI-HRMS
and HPLC revealed the presence of additional anionic products,
including nitrite, hyponitrite, nitrate, sulfite, sulfate, thiosulfate,
and polythionates (Fig. 3C and SI Appendix, Fig. S6), with evi-
dence for traces of a persulfide NONOate ([ONN(OH)S2]
−).
The previously reported intermediate in the formation of SSNO−,
thionitrite (SNO−)/thionitrous acid (HSNO) (9, 10, 21, 22, 26),
proved impossible to be detected from RSNO/sulfide mixtures
using this technique, even with cryospray ionization at −20 °C (SI
Appendix, Figs. S8 and S9); although stable at very low temperature
(12 K) in a frozen argon matrix (24), detection of HSNO at room
temperature as presented in an earlier publication (21) is difficult
to understand.
Collectively, these data suggest that the chemical foundation
of the NO/sulfide cross-talk is not limited to formation of a single
molecular entity but is underpinned by a mixture of compounds,
including HSn
− and two S/N-hybrid molecules (SSNO− and
SULFI/NO) along with other nitrogen oxides and sulfoxy spe-
cies. With sulfide in abundance, HSn
− and SSNO− are the major
products accumulating.
NO- and HNO-Mediated Bioactivity in Vitro. Both SSNO− and
SULFI/NO may have the potential to generate NO and/or its
redox congener, HNO (26, 36). We, therefore, compared the NO
and HNO releasing properties of SSNO−-enriched mixtures
(“SSNO− mix”) with the properties of solutions of authentic
SULFI/NO. SSNO− is a potent NO donor as assessed by chem-
iluminescence (Fig. 4A) and a weak HNO donor as assessed by
triarylphosphine trapping (Fig. 4D) (37); however, no signal was
obtained using the specific nitroxyl probe P-Rhod (38) (Fig. 4B).
Other methods, such as methemoglobin trapping and ferricyanide
oxidation of HNO into NO, suffer from artifacts caused by reaction
with sulfide (SI Appendix, Fig. S10). In agreement with earlier
findings (39), we found SULFI/NO to be a weak combined NO/
HNO donor compared with DEA/NO and Angeli’s salt (Fig. 4 B
and C and SI Appendix, Figs. S10 and S11). Interestingly, N2O (the
main decomposition product of SULFI/NO) is generated at high
yield under aerobic and anaerobic conditions on reaction of sulfide
with DEA/NO (Fig. 4C) and RSNOs (SI Appendix, Fig. S11). Thus,
as with acidified nitrite and sulfide (12), NO, HNO, and N2O are
common end products of the reaction of sulfide with NO or RSNOs.
As shown recently, the SSNO− mix concentration-dependently
increases cGMP in RFL-6 cells (26) and relaxes aortic rings (28)
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Fig. 3. Identification by ESI-HRMS of SULFI/NO and SSNO− as S/N-hybrid
species formed by the reaction of sulfide with DEA/NO or SNAP. (A) For-
mation of SSNO− from DEA/NO (1 mM)/sulfide (2 mM) and SNAP (1 mM)/
sulfide (2 mM) incubates. (Left) Mass and (Center) fragmentation spectra of
SSNO− (compound 1) from DEA-NO-sulfide incubates; (Right) shift in m/z
of SSNO− using an equimolar mixture of 14N/15N-labeled SNAP with sulfide.
(B) Formation of SULFI/NO (compound 2) from DEA/NO (1 mM)/sulfide
(2 mM) and SNAP (1 mM)/sulfide (2 mM) incubates. (Left) Mass and (Center)
fragmentation spectra of SULFI/NO; (Right) m/z shifts of one and two by
reacting an equimolar mixture of 15N/14N-SNAP (1 mM) with sulfide (2 mM).
(C) Extracted ion chromatograms showing SNAP consumption accompanied
by formation of SULFI/NO and SSNO− together with polysulfides (compound 3;
n = 2–7), including monoprotonated tri-, tetra-, and pentasulfide (HS3
−, HS4
−,
and HS5
−, respectively), sulfite (HSO3
−), sulfate (HSO4
−), and thiosulfate
(HS2O3
−). SI Appendix, Table S7 has details on predicted molecular masses.
A.U., arbitrary unit; DEA/NO, dietylamine NONOate; SNAP, S-nitroso-N-acetyl-
penicillamine; m/z, mass-to-charge ratio.
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in an NO- and sGC-dependent manner. In Fig. 4E, we show that
low concentrations of SULFI/NO do not increase intracellular
cGMP levels, except in the presence of very high concentrations
of superoxide dismutase (SOD) facilitating noncatalytic, copper-
mediated conversion of HNO to NO (40). The effects of SULFI/
NO were quenched by trapping either HNO by cysteine or NO
by cPTIO (Fig. 4F). HSn
− and colloidal sulfur did not signifi-
cantly increase cGMP. Considering that SSNO− and SULFI/NO
are the major S/N-hybrid molecules formed from sulfide and NO
and that SULFI/NO is rather inefficient at releasing NO/HNO,
these observations suggest that SSNO− is the main carrier of
bioactivity in the NO/sulfide interaction. The formation of sulfite
from sulfide may be important in redox switching by virtue of
sulfite’s ability to trap NO (SI Appendix, Fig. S3) and form
SULFI/NO, allowing conversion of NO into HNO.
In Vivo Bioactivity: Vascular and Cardiac Effects. The in vivo bio-
activity of the SSNO− mix was compared with authentic SULFI/
NO by assessing effects on hemodynamics and cardiac function
in rats (Fig. 5 and SI Appendix, Tables S3–S6). Acute adminis-
tration of SSNO− dose-dependently decreases blood pressure,
whereas only the highest dose of SULFI/NO tested lowered
blood pressure significantly (Fig. 5A). However, in contrast to
SSNO−, SULFI/NO increases cardiac output, stroke volume, and
aortic peak flow velocity without significant changes in heart
rate, indicative of increased myocardial contractility (Fig. 5B and
SI Appendix, Table S5). Continuous i.v. infusion of SSNO− in-
duces a transient but significant drop in blood pressure followed
by an increase in cardiac output (Fig. 5 C and D), whereas heart
rate remains constant (SI Appendix, Table S6). By comparison,
continuous infusion of SULFI/NO had less of an effect on blood
pressure than SSNO− but produced a dramatic increase in car-
diac contractility (Fig. 5 C and D); these results suggest that the
positive inotropic effects of the SSNO− mix may, in fact, be
mediated by the presence of SULFI/NO in the reaction mixture.
The i.v. bolus administration of a mixture of HSn
− was found to
be of similar potency at lowering blood pressure as sulfide, but
HSn
− seems to be endowed with a longer duration of action (SI
Appendix, Figs. S12 and 13A); preliminary results suggest that
they may also increase vascular compliance (SI Appendix, Fig.
S13). Collectively, our results indicate that the three major re-
action products of the NO/sulfide interaction all display potent
bioactivity, with a distinct cardiovascular profile for each class
of species.
Discussion
The results of this study show that sulfide reacts with NO under
physiologically relevant conditions to form three main bioactive
products: SSNO−, HSn
− (where n = 2–7), and SULFI/NO.
Specifically, we show that (i) in vivo sulfide administration
modulates endogenous NO bioavailability; (ii) SSNO− is formed
by intermediate polysulfide formation, accumulates at higher
sulfide concentrations, is resistant to attack by other thiols, acts
as an efficient NO and sulfane sulfur donor, and lowers blood
pressure; (iii) HSn
− are also products of the NO/sulfide inter-
action, are intermediates as well as decomposition products of
SSNO−, and lower blood pressure; (iv) SULFI/NO is a weak
combined NO/HNO donor that has only mild blood pressure
lowering but very pronounced positive inotropic effects; and
(v) various other reaction products, including nitrogen oxides
and sulfoxy species, are formed and likely also contribute to
the bioactivity of both NO and sulfide. Importantly, our results
suggest that the fates of NO and sulfide are intimately inter-
twined wherever they are cogenerated in biology; as a corollary,
the biological actions of NO and H2S can be neither considered
nor studied in isolation, because they form a network of coupled
chemical reactions that gives rise to formation of multiple new
chemical entities with distinct bioactivity profiles. This un-
expectedly rich chemistry would seem to provide nature with
ample opportunities for modulation of various fundamental
biological and pathophysiological processes related to, for ex-
ample, electron transfer, sulfur trafficking, and redox regulation.
A B
C D
E F
Fig. 4. NO and HNO bioactivity of SSNO− and SULFI/NO in vitro. The scheme
shows that the release of NO and HNO from SSNO− and SULFI/NO leads to
activation of sGC in cells. (A) Kinetics of NO release from SSNO− after in-
cubation of SNAP (0.1 or 1 mM) and Na2S (1 or 10 mM) for 1 min as de-
termined by chemiluminescence (final dilution of 1:100). (Inset) NO release
from authentic SULFI/NO (100 μM) in the absence of sulfide. (B) Release of
nitroxyl (HNO) as assessed by P-Rhod fluorescence from increasing concen-
trations of SULFI/NO (blue) and SSNO− (orange; 1 mM SNAP, 10 mM Na2S;
gassed). ΔFI, fluorescence intensity-background. (C) The reaction of DEA/NO
(10–200 μM) with sulfide (100 μM) generates N2O over prolonged periods of
time. (D) HNO scavenging by triphenylphosphine reveals that part of the
N2O formed during the DEA/NO/sulfide reaction originates from HNO di-
merization/dehydration. ***Dunnett’s P < 0.001. (E) SSNO− (20 μM) activates
sGC in RFL-6 cells in both the presence and the absence of SOD, whereas
equivalent concentrations of SULFI/NO (10 μM) activate sGC only in the
presence of SOD after conversion of HNO into NO (n = 6–12; one-way
ANOVA, P < 0.001). **Dunnett’s P < 0.01; ***Dunnett’s P < 0.001; §t test vs.
untreated P < 0.001 (paired t test P = 0.0056); #P < 0.01 vs. 10 μM SULFI/NO
without SOD. n.s., nonsignificant. (F) Higher concentrations of SULFI/NO (100
μM) activate sGC even in the absence of added SOD, an effect that is abol-
ished by the NO scavenger cPTIO (500 μM) and the HNO scavenger Cys
(1 mM; n = 5–10; one-way ANOVA, P < 0.001; F = 27.14). *Sidak’s P < 0.05 vs.
CTRL; ***Sidak’s P < 0.001 vs. CTRL; #P < 0.01 vs. 100 μM SULFI/NO; ##P <
0.001 vs. 100 μM SULFI/NO. cPTIO, 2-(4-Carboxyphenyl)-4,4,5,5-tetramethyli-
midazoline-1-oxyl-3-oxide; CTRL, control; Cys, cysteine; DEA/NO, diethylamine
NONOate; IBMX, 3-isobutyl-1-metylxanthine; SOD, superoxide dismutase;
TXPTS, triarylphosphine.
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Chemistry of the Reaction Between Sulfide and NO. A reaction be-
tween NO and sulfide was first described almost a century ago
(refs. 11, 41, and 42 and references therein). The main products
of this reaction were found to be nitrogen oxides (NO, N2, and
N2O; measured in the gas phase) and sulfur-bearing anionic
solutes, including SSNO− and HSn
− (9, 10). These are essentially
the same products that were later described in the reaction of
RSNOs with sulfide (26, 27) without an understanding of de-
tailed reaction mechanisms. SULFI/NO formation was described
by others (9, 42–44), although only in one case (9) in the context
of sulfide. We here describe a singular process that occurs under
biologically relevant conditions and characterizes the interac-
tion between NO or RSNOs and sulfide. This process comprises
cascading chemical reactions, giving rise to formation of three
main anionic products (SSNO−, HSn
−, and SULFI/NO) accom-
panied by the release of H2S, NO, HNO and N2O, NO2
−, and
NO3
− as well as sulfoxy species, such as SO4
2−, S2O3
2−, SO4
2−,
and polythionates. Identification of the S/N-hybrid species was
achieved using a variety of techniques, including ESI-HRMS
combined with stable isotope labeling.
On the basis of the products identified here and elsewhere (9–
11, 41–44), it is possible to propose a unified reaction scheme
(summarized in Fig. 6 and explained in more detail in SI Ap-
pendix). Although it is not difficult to rationalize how HS− (or
the even stronger nucleophile HSS−) reacts with RSNOs to form
HSSNO/SSNO− (13, 26), formation of the latter from NO and
sulfide is less straightforward. The simplest assumption is that,
under aerobic conditions, sulfide is nitrosated by NO autoxida-
tion products (NO2 and N2O3), initially leading to transient
formation of HSNO with subsequent attack by another HSS− to
form SSNO− (reactions 1–3 in Fig. 6). However, our results with
DEA/NO and aqueous NO solution clearly show that the re-
action also occurs (to about the same extent, although with
slower kinetics) under strict exclusion of oxygen, showing that
there must be another route to formation of SSNO−. A second
possibility involves formation of thiyl and perthiyl radicals (S•−
and SS•−) (reactions 4 and 6 in Fig. 6), which can trap NO di-
rectly to form SNO− and SSNO− (reactions 5 and 7 in Fig. 6).
Formation of S•− can take place by one-electron oxidation of
sulfide after (i) reaction with O2 (rather inefficient) or (ii)
transition metal catalysis (reaction 4 in Fig. 6); alternatively, S•−
and SS•− might be also formed by HSNO or SSNO− hemolysis
after these species are formed through other routes (reactions 16
and 17 in Fig. 6) or by homolytic cleavage of long-chain HSn
−
(e.g., reaction 20 in Fig. 6), although the driving force for HSn
−
decomposition to anion radicals is unclear. Nevertheless, as
shown here and according to reactions 3 and 7 in Fig. 6, HSn
− (or
its radical intermediates) are substrates of SSNO− synthesis.
Previous work has shown that relatively pure solutions of SSNO−
in acetone can be obtained by passing NO through solutions of
inorganic/organic polysulfide as evidenced by 15N NMR (10) and
X-ray crystallographic studies (35).
In addition to HSn
− and SSNO−, we identified SULFI/NO (36,
42, 45) as another important product of the reaction of sulfide
A B
C D
Fig. 5. SSNO− and SULFI/NO show distinct bioactivity in rats in vivo. (A) i.v.
Injection of the SSNO− mix (dose range of 0.03–3 μmol/kg) leads to signifi-
cant dose-dependent decreases of mean arterial pressure (MAP), whereas
only the highest dose of SULFI/NO (3 μmol/kg) decreases MAP (n = 3 per
group; RM two-way ANOVA, P < 0.01 for treatment and doses). *Sidak’s P <
0.01; **Sidak’s P < 0.01. At comparable doses, NaHS (1.8 and 3.5 μmol/kg)
does not significantly affect blood pressure. (B) The SSNO− mix (dose range
of 0.03–3 μmol/kg) does not affect cardiac function, whereas higher doses of
SULFI/NO (3 μmol/kg) increase cardiac contractility, which was assessed by
changes in velocity time index (VTI), cardiac output (CO), and peak flow
velocity (PFV; n = 3 per group; RM two-way ANOVA, P < 0.01) (SI Appendix,
Tables S3–S5). (Inset) NaHS (dose range of 1.8–18 μmol/kg) does not affect
VTI. #t Test P < 0.05. (C) Continuous infusion of the SSNO−mix (0.16 μmol/kg
per min) significantly decreases MAP compared with baseline, and its effect
is more rapid in onset compared with that of NaHS (2.9 μmol/kg per min).
Infusion of SULFI/NO equimolar to SSNO− (0.16 μmol/kg per min) has only a
mild, nonsignificant effect on blood pressure compared with vehicle control
(SI Appendix, Table S6) (n = 3 per group; RM two-way ANOVA treatments,
P = 0.00471). *Sidak’s P < 0.05 vs. baseline; **Sidak’s P < 0.01 vs. baseline; §P <
0.01 vs. NaHS. (D) Continuous infusion of SSNO−mix (0.16 μmol/kg per minute)
increases cardiac contractility (VTI, CO, and PFV) after 60 and 120 min of in-
fusion (n = 3), whereas NaHS (2.9 μmol/kg per minute; shown in Inset) does not
have any effect. SULFI/NO markedly increases cardiac contractility already
10 min after the start of infusion (n = 3; RM two-way ANOVA, P < 0.0001).
*Sidak’s P < 0.05 vs. vehicle; **Sidak’s P < 0.01 vs. vehicle; ***Sidak’s P < 0.001
vs. vehicle; #two-way ANOVA SULFI/NO vs. SSNO, P = 0.0046. RM, repeated
measurements.
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The pKa values of HS• and HSS• are unknown but likely exceed 7; therefore,
at pH 7.4, these species are radical anions.
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with either NO or RSNOs. We also found traces of [ONN(OH)S2]
−
as predicted by Seel and Wagner (9). A likely precursor of
SULFI/NO formation from NO and sulfide is sulfite (SO3
2−)
(reaction 15 in Fig. 6), which was suggested by others not only
for the reaction of sulfide with NO under anoxia (9, 11) but
also, as a result of the reaction of NO with thiosulfate (S2O3
2−)
and S2O4
2− (11). In aqueous solution, sulfite may be formed by
reaction of sulfide with O2 by formation of SO2
•− and S2O4
2− (46)
(reactions 9–12 in Fig. 6), formation of S2O3
2− originating from
radical reactions (by SO2
•−) (reactions 9–13 in Fig. 6), or hy-
drolysis of HONS (a product of HSNO isomerization) as pro-
posed by Goehring and Messner (23). Because no SO3
2− was
detected by ESI-HRMS in freshly prepared sulfide stock solu-
tions and sulfide autoxidation is a rather slow process, production
of S2O3
2− through radical reactions and/or HONS/HSNO seems
to be the most plausible route.
The main pathways of decomposition of the key reaction
products are as follows (Fig. 6): SSNO− can undergo homolytic
cleavage to SS•− and NO• (reaction 17 in Fig. 6) or secondary
reaction with sulfide (reaction 19 in Fig. 6), which according to
Seel and Wagner (10), is not efficient, because they observed an
equilibrium between the trisulfide radical and NO in sealed
systems, making SSNO− rather stable in excess sulfide (10). HSn
−
may undergo polymerization reaction to cyclo-octasulfur (S8)
and/or homolytic cleavage to form sulfur radicals (see above)
(reaction 20 in Fig. 6); in the presence of strong nucleophiles
(such as DTT), polysulfides undergo decomposition to sulfide, a
property that we here used to distinguish them from SSNO−.
Decomposition of SULFI/NO leads to formation of SO3
2−, SO4
2−,
and N2O (reactions 21–24 in Fig. 6). Although it has been pro-
posed that this process occurs directly (reaction 21 in Fig. 6) (36),
the formation of both HNO and NO from hyponitrite (ON:NOH−)
has been proposed by others (reactions 22 and 23 in Fig. 6) (42–
44). Indeed, evidence for trace levels of ON:NOH− in incubation
mixtures of both SULFI/NO and DEA/NO (but not SNAP) with
sulfide was observed by us using ESI-HRMS (SI Appendix, Fig. S6).
Authentic sodium hyponitrite was found to release NO at pH 7.4,
which was markedly enhanced in the presence of the one-electron
oxidant ferricyanide, consistent with the generation of both NO
and HNO (SI Appendix, Fig. S7) (47). ON = NOH− is known to
decompose to N2O and water after protonation to hyponitrous acid
(HNO = NOH).
Parallel reactions lead to formation of HNO, superoxide (O2
•−),
and peroxynitrite (ONOO−). These reactions include reduction of
NO to HNO by HSn
−, very potent radical reducing/trapping agents
(48), and oxidation of O2 or NO to O2
•− or ONOO−, respectively,
by reaction with sulfur-centered radicals. Moreover, ONOO−
may also be formed after reaction of HNO with O2; these pos-
sibilities are consistent with the rapid consumption of O2 in the
reaction (26). Finally, HNO can be reduced by sulfide to hy-
droxylamine (NH2OH), and nitrosation of NH2OH results in
formation of N2O (12).
Chemical Biology of SSNO−, Polysulfides, and SULFI/NO. The fact that
the above reactions occur in aqueous buffers at pH 7.4 does not
necessarily mean that they are relevant to biology. What follows
is a discussion about whether the chemical properties of SSNO−,
HSn
−, and SULFI/NO are compatible with the biological situation,
such that these molecules can conceivably play a role in cell sig-
naling and/or interorgan transport of NO and sulfur equivalents.
SSNO− is a bioactive product with unusual properties: it is
stable in the presence of millimolar concentrations of other thiols
[sulfide, (homo)cysteine, and glutathione], carries and releases NO,
and generates HSn
− on decomposition. These properties suggest
it would be sufficiently stable if formed in the cellular milieu to
participate in and contribute to NO/sulfur trafficking (13, 26).
These properties clearly distinguish SSNO− [and its protonated
form perthionitrous acid (HSSNO)] from SNO−/HSNO (13, 26).
SSNO− is considerably more stable than HSNO, because the latter
undergoes rapid isomerization, hemolysis, and polymerization (13).
Moreover, HSNO can undergo rapid nucleophilic attack by HS− to
give HSSH and NO− (reacting with O2 to form ONOO
−), whereas
the electron density of the proximate sulfur in HSSNO is increased,
making it less susceptible to nucleophilic attack by HS− and re-
action with metals (e.g., Cu+). Of note, SSNO− exerts faster and
more prominent vasorelaxation compared with its precursor and
the prototypical nitrosothiol, GSNO (28), indicative of the ease
with which it can cross cell membranes and release NO.
HSn
− (and their organic counterparts) are not resistant to
reducing conditions and high concentrations of thiols, and con-
tain a highly reactive sulfane sulfur (49, 50). Polysulfides were
proposed to be the bioactive molecules responsible for “H2S
signaling” and much of the physiological action of sulfide in cells
(31, 48, 49). In addition, they are believed to act as storage or
buffer molecules of H2S, with surprisingly high concentrations
measured in murine organs/tissues (31). Although their chem-
istry is reasonably well-understood (48, 50), biosynthetic path-
ways, speciation, and modes of action in the biological environ-
ment are still poorly defined. The results of this study suggest
that HSn
− are also intermediates in SSNO− formation, possibly
through homolytic cleavage to radical species and subsequent
reaction with NO. Thus, in addition to their enzymatic formation
(33) and as a consequence of sulfide oxidation (50), reaction of
sulfide with NO or nitrosothiols may provide another pathway to
their production in cells and tissues.
SULFI/NO arises as a result of the trapping of two molecules
of NO by sulfite (36, 39, 45), a reaction originally described by
Davy in 1802. The substance is also known as dinitrososulfite
(51), “Pelouze’s salt,” or “Stickoxid-sulfite” in the German lit-
erature (ref. 42 and references therein). Its structural charac-
teristics were revealed about 100 years later using IR spectros-
copy (51) and confirmed by alternative chemical synthesis (42). It
belongs to a class of compounds now better known as dia-
zeniumdiolates or NONOates (36). Consistent with earlier re-
ports, we found that SULFI/NO has similar stability character-
istics as other diazeniumdiolates (36, 39, 45, 52), cogenerates
small amounts of NO and HNO at pH 7.4, and releases N2O
in high yields. An unexpected yet inevitable consequence of its
formation in the NO/sulfide system is that SULFI/NO is formed
(in addition to SSNO− and HSn
−) whenever NO and sulfide are
cogenerated; sulfite generation, thus, results in the scavenging of
NO, with consecutive redox conversion of part of this NO to
HNO. This unexpected chemistry propels this molecule, a rather
ineffective NO donor and vasodilator (39), from the chemists’
curiosity cabinet to the forefront of biological signaling. Proof for
its formation in living organisms will require development of
sufficiently sensitive analytical techniques to monitor its formation
and fate, but the likelihood of its existence in real life is intriguing.
Taken together, the chemical biology of the three major
products of the NO/sulfide reaction system ranges from sulfane
sulfur signaling (SSNO− and polysulfides) through NO release
(SSNO− and SULFI/NO) and NO scavenging (sulfite) to nitroxyl
signaling (SULFI/NO), with generation of several other sulfoxy
and nitrogen oxide metabolites with known and distinct bio-
activity profiles.
Bioactivity of SSNO−, Polysulfides, and SULFI/NO. The different
chemical properties attributed to SSNO−, HSn
−, and SULFI/NO
translate into distinct bioactivities in vitro and in vivo. As shown
here and elsewhere (26, 28), the SSNO− mixture (produced from
either DEA/NO or SNAP with excess sulfide) contains high
concentrations of SSNO− and HSn
−, releases NO, is a potent
sGC stimulator in the NO reporter cell line RFL-6 (26), induces
NO-mediated vasorelaxation in isolated aortic tissue (28), and
significantly decreases blood pressure in a dose-dependent fashion
with minor effects on cardiac function. No changes in any of these
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parameters were observed by equivalent concentrations/doses of
sulfide alone. Control experiments with HSn
− suggest that NO-
independent effects on blood pressure may be, in part, dependent
on the presence of HSn
− in the mixture but independent of SULFI/
NO. Only rather high (>100 μM) concentrations of SULFI/NO (but
not HSn
− or S8) activated sGC in RFL-6 cells; these effects were
fully inhibited by addition of cysteine (HNO scavenger) or cPTIO
(NO scavenger) and potentiated by high but not low concentrations
of SOD converting HNO into NO (40, 47). These results are con-
sistent with its predicted chemical biology as a relatively weak
combined NO/HNO donor. However, SULFI/NO dramatically in-
creased cardiac output, stroke volume (measured as the velocity–
time integral), and peak blood flow velocity while affecting blood
pressure and heart rate only minimally (except at high doses), in-
dicative of its propensity to enhance cardiac contractility, an effect
likely mediated by the generation of HNO.
In aggregate, these results show that SSNO− is a potent NO
donor mainly affecting peripheral vascular resistance, whereas
SULFI/NO is a rather weak NO/HNO donor that affects the
tone of resistant vessels to a lesser degree but potently increases
cardiac contractility. Although SSNO− is a major reaction product
in NO/sulfide-containing mixtures, one important limitation worth
highlighting is that, at present, the biological properties of SSNO−
cannot be studied separately from SULFI/NO, sulfide/HSn
−, and
other reaction products formed. Moreover, the rich possibilities
for interaction between defined constituents of the reaction mix-
ture may profoundly affect the chemistry and bioactivity of indi-
vidual species in the biological setting. For example, by incubating
SULFI/NO with sulfide, we observed formation of HSn
−. Never-
theless, our results clearly show that NO and sulfide react with
each other; wherever cogenerated, their reaction leads to forma-
tion of molecules with bioactivities distinct from the parent com-
pounds, resulting in quenching, redox switching, or release/transport
of NO bioactivity.
What Is the Significance of These Reactions for the Sulfide/NO Cross-
Talk in Vivo? Our in vivo data suggest that the well-known scav-
enging and potentiating effects of sulfide on NO bioavailability
in vitro (19, 26) and vascular function in vivo (18) correlate with
changes in NO bioavailability. In the first 30 min of sulfide in-
fusion, we observed a drop in NO-heme levels within erythrocytes,
whereas no significant changes in hemodynamic parameters were
apparent; after 1 h of infusion, allowing sulfide accumulation (53),
increases in systemic NO bioavailability (i.e., levels of NO-heme
and nitroso species) were accompanied by corresponding de-
creases in blood pressure. These results are consistent with NO
scavenging effects after the addition of low concentrations of
sulfide as detected by chemiluminescence as well as in RFL-6 cells
and other cell types as shown here and elsewhere (19, 26). A
decrease in circulating nitrite and RXNO levels was observed in
mice lacking the sulfide-producing enzyme cystathionine-γ-lyase
(54); however, this result was ascribed to effects of sulfide on
endothelial NO synthase activity. However, effects of sulfide on
NOS activity in this context are unlikely, considering that the ef-
fects of NOS inhibition on circulating and tissue NO metabolites
are less rapid than the functional effects of sulfide observed.
The molecular basis that accounts for scavenging and poten-
tiation of NO bioactivity by sulfide is presently unclear. These
effects have been ascribed to formation of a nitrosothiol (19),
mutual regulation of enzymatic pathways (e.g., endothelial nitric
oxide synthase) (54), modulation of PDE (55), and/or targeting
of different vascular beds (56). An interesting alternative possi-
bility that would seem to warrant additional investigation is that
sulfide might modulate redox-dependent control mechanisms,
regulating vascular tone independently of sGC, such as, for ex-
ample, through modulation of the redox state of PKGIα by oxi-
dative modification of Cys42 (57). This notion would be consistent
with the observation that the vasoactive effects of sulfide are
partially attenuated in aortic rings from PKG1−/− mice (58). It is
also possible that the effects of sulfide are caused by a chemical
interaction by (i) formation of S-nitroso species (such as SSNO−)
acting as a temporary “NO sink” that is able to release NO
farther downstream; (ii) formation of reactive sulfoxy inter-
mediates, such as SO2
• or SO3
2−, forming NO complexes with a
low NO-releasing potential, such as SULFI/NO; or (iii) forma-
tion of thiyl radicals (such as HS• and HSS•) by reaction with O2.
The latter is consistent with our earlier observation that O2 is
consumed in the reaction (26) and would lead to formation of
O2
•− and NO scavenging as a result of peroxynitrite (ONOO−)
generation. Both formation of sulfoxy species and O2 consumption
are interesting observations not only from a chemical perspective
but also, because mitochondrial sulfide oxidation has been linked
to physiological oxygen sensing (59) and SO3
2−/S2O3
2− are reduced
to HS− in mitochondria (59). Final proof of the relevance of these
chemical pathways in biological systems will require the detection
of these S/N-hybrid molecules, as shown for RSSH (31), in cells
and tissues. Similarly important in this context will be a careful
kinetic assessment of the reaction yields depending on the rates of
formation of NO and sulfide in subcellular compartments. Because
such evaluation does not seem to be possible using current analytical
techniques, the development of a novel quantitative/nondestructive
methodology for in situ detection and monitoring of those mole-
cules in biological matrices merits additional investigation.
Summary and Conclusions
Understanding the basic chemical principles that govern the in-
teractions between sulfide and NO is essential to interpreting
and untangling the conflicting observations about mutual po-
tentiating and inhibitory effects presented in the literature. Here,
we show that the reaction between sulfide and NO leads to
formation of different bioactive intermediates (including SSNO−,
HSn
−, and SULFI/NO) capable of scavenging, transporting, and
releasing NO and generating its redox congeners HNO, N2O, and
sulfane sulfur. Each of these products is characterized by a specific
biological chemistry and the potential to release other bioactive
mediators. With the exception of SULFI/NO, the bioactivity of
HSn
− and SSNO− cannot be studied in isolation and/or the ab-
sence of sulfide at present. Nevertheless, by careful comparison of
the effects of different mixtures of these components, we conclude
that SSNO− is a potent NO donor, resistant to the reducing milieu
of the cell, and able to release both NO and HSn
−. SULFI/NO is a
weak combined NO/HNO donor and generator of N2O with po-
tent effects on the heart. Formation of its precursor sulfite and
generation of sulfur and/or oxygen-centered free radicals may be
responsible for the scavenging effects of sulfide on NO bio-
availability. Polysulfides may be formed secondary to the reaction
of sulfide with NO, either through HSNO or after decomposition
of SSNO−, and may also contribute to NO scavenging and sulfane
sulfur signaling. Although admittedly even more speculative, some
of this chemistry may also help explain the “Janus-like” face of
NO (i.e., the often opposing biological effects of low and high
concentrations observed in physiology and pathophysiology). In
any case, our findings open the door to a new field of research
with SSNO−, HSn
−, and SULFI/NO taking center stage as bi-
ologically important mediators of both the NO and H2S trans-
duction pathways. Although the cardiovascular system has been
the target of our current efforts, this chemical interaction is likely
to be relevant to cell/organelle signaling in many other systems,
including neuronal and immune cells, plants, and prokaryotes
as exemplified by the recent work on antibiotic resistance by
bacterial NO/H2S production (17). Beyond its likely signifi-
cance for biology and redox signaling, our results may also be of
significance for environmental chemistry pertinent to marine and
atmospheric processes.
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Materials and Methods
A complete and more detailed description of the materials and methods
used is provided in SI Appendix.
Preparation of Stock Solutions of NO Donors, SULFI/NO, Sulfide, and SSNO−.
The potassium salt of SULFI/NO was synthesized as described by Drago and
coworkers (60). Stock solutions of DEA/NO, DETA/NO, Sper/NO, SULFI/NO,
and Angeli’s salt were freshly prepared in 0.01 M NaOH, diluted in PBS, and
used immediately. Aqueous stock solutions of 15N-SNAP or SNAP were
freshly prepared either from crystalline material or through reaction of the
reduced thiols with acidified nitrite (61) and used immediately. Saturated
aqueous solutions of NO were prepared and kept sealed under argon as
described (62). Sulfide stock solutions for in vitro use (e.g., in cell culture
experiments) were prepared fresh before each experiment by dissolving
anhydrous Na2S in a strong buffer (1 M Tris or phosphate buffer, pH 7.4) and
diluting further in 100 mM Tris or 50–100 mM phosphate buffer (pH 7.4)
immediately before use. For in vivo experiments, NaHS stock solutions were
prepared in 300 mM phosphate buffer (pH 7.4), diluted in PBS (pH 7.4), and
used immediately (10 mg/mL = 176.7 mM NaHS; anhydrous; Alfa Aesar).
Although all precautions were undertaken to avoid the presence of products
of sulfide oxidation in the stock solutions, including polysulfide, their pres-
ence in stock solutions cannot be excluded. Stock solutions of SSNO− were
prepared by reacting 1 mM SNAP with 10 mM Na2S in 1 mL PBS or 100 mM
Tris (pH 7.4). After 10 min of incubation at RT in the dark, excess sulfide was
removed by 10 min of bubbling with N2. The (theoretical) maximal yield of
SSNO− under these conditions is 1 mM, corresponding to the concentration
of added nitrosothiol (SI Appendix, Fig. S5 shows the experimental de-
termination of reaction yield). For in vivo experiments, the SSNO− solution
was prepared in phosphate buffer (pH 7.4) and further diluted in PBS to
obtain the doses indicated for bolus i.v. injection or used directly for con-
tinuous i.v. infusion.
Effects of Sulfide, SSNO−, SULFI/NO, and Polysulfides on Cardiovascular Hemo-
dynamics and Circulating NO Metabolites. All animal experiments were ap-
proved either by the Institutional Animal Care and Use Committee (IACUC) at
Boston University School of Medicine (Boston, MA), the University College
London (London, UK), or the State Veterinary and Food Administration of
the Slovak Republic. All procedures were conducted in male Wistar rats (250–
300 g; Charles River) anesthetized with 2% (vol/vol) isofluorane. Briefly, the
effects of bolus i.v. injection of increasing doses of NaHS (1.8–18 μmol/kg),
SSNO− mix (0.03–3 μmol/kg), or SULFI/NO (0.03–3 μmol/kg) in PBS or vehicle
alone on cardiovascular hemodynamics and circulating NO stores were
assessed at 10-min intervals. Continuous i.v. infusions of NaHS (2.8 μmol/kg
per min in PBS), SSNO− (0.16 μmol/kg per min in PBS), SULFI/NO (0.16 μmol/kg
per min in 25 mM NaOH, 0.9% NaCl), or the respective vehicle (PBS or 25 mM
NaOH, 0.9% NaCl) were performed at a rate of 10 mL/kg per hour through the
right internal jugular venous line. Continuous monitoring of mean arterial
pressure and blood withdrawal was from an indwelling arterial (left common
carotid) line. Blood was taken at defined time points (0, 5, 10, 30, 60, and
120 min) and processed as previously described for determination of NO me-
tabolite concentrations by ion chromatography and gas-phase chemilumines-
cence (63). Cardiac function and heart rate were assessed by transthoracic
echocardiography using a Vivid 7 (GE Healthcare) as described (64). A rectal
probe (TES Electrical Electronic Corp.) inserted 3 cm in depth was used to
measure core temperature.
Effects of Sulfide on NO Bioactivity and Detection of NO Release and Bioactivity
of SSNO− and SULFI/NO in RFL-6 Cells. The effects of sulfide on Sper/NO-mediated
activation of sGC were determined by measuring changes in intracellular cGMP
levels in RFL-6 cells pretreated with a phosphodiesterase inhibitor (500 μM
3-isobutyl-1-metylxanthine), and then treated with 100 μM Sper/NO for 20 min
in the absence or presence of increasing concentrations of sulfide (1, 10, and
100 μMNa2S in 100 mM Tris, pH 7.4) as described (26). The NO/HNO bioactivities
of SSNO− and SULFI/NOwere compared by treating 3-isobutyl-1-metylxanthine–
pretreated cells (as above) with either 20 μM SSNO− mix or 1, 10, and 100 μM
SULFI/NO for 20 min. To test for HNO bioactivity, ∼7,000 U/mL SOD was added
directly to the treatment medium 5 min before addition of SSNO− or SULFI/NO
to enable extracellular conversion of HNO into NO. In select experiments, an NO
scavenger (cPTIO; 500 μM) or a nitroxyl scavenger (1 mM Cys) was added 5 min
before the other treatments. Intracellular cGMP levels and protein content
were assessed in cell lysates using a DetectXHigh Sensitivity Direct cGMP Kit
(Arbor Assay; Biotrend) and Roti−Nanoquant (Carl Roth GmbH + Co. KG), re-
spectively. Data were normalized for protein content and expressed as folds of
untreated control to further account for the variability in sGC expression levels
of RFL-6 cells of different batches and passages.
Detection of SSNO−, SULFI/NO, and Polysulfides by UV-Visible Spectroscopy and
HRMS. The spectroscopic and kinetic behaviors of the reaction between
sulfide (1–10 mM) and NO (0.2 mM), DEA/NO (0.5–3 mM), or SNAP (0.2–1 mM)
were followed by rapid scanning UV-visible spectroscopy as described (26). The
identification of the reaction products was achieved by HRMS using an LTQ
Orbitrap XL Hybrid Linear Ion Trap–Orbitrap Mass Spectrometer equipped with
a nanospray ionization source controlled with XCalibur 2.1 (Thermo-Fisher).
Samples for HRMS were mixed in 50 mM (NH4)3PO4 buffer (pH 7.4), mixed
1:5 with acetonitrile through a T piece, and infused directly into the ion
source. Spectra were acquired in negative ion mode with a spray voltage of
5 kV and nitrogen as sheath gas; capillary temperature was set at 300 °C,
and capillary voltage was set at 20 V. Instrument parameters, especially
those of the ion optics, were optimized for each individual compound of
interest. Elemental analysis based on accurate mass and a priori information
of likely elemental composition and isotope distribution simulation were
performed using XCalibur 2.1.
Time-Resolved Measurement of NO Trapping and NO Release by Chemiluminescence.
Trapping by Na2S (33.4 and 334 μM) of NO released from DETA/NO (33.4 μM)
and NO released from SSNO-containing mixtures (1–100 μM) after 1 min of
incubation of SNAP and sulfide, SULFI/NO (100 μM), and SNAP (10 μM) alone
was monitored by gas-phase chemiluminescence (CLD 77:00 AM sp; Eco-
physics) using a custom-designed, water-jacketed glass reaction chamber
(15 mL total volume) continuously bubbled with nitrogen or air as described
elsewhere (26).
Detection of HNO Release by P-Rhod Fluorescence. HNO release form SSNO−
(0.001–1 mM) and SULFI/NO (0.001–1 mM) was determined by using the
HNO-specific probe P-Rhod (stock 50 mM in DMSO) (38). Briefly, N2 gassed
SSNO− mix (1 mM SNAP, 10 mM Na2S), SULFI/NO (1 mM), or Angeli’s salt
(1 mM; all in 100 mM Tris·HCl, pH 7.4) were serially diluted in Tris·HCl in a
dark 96-well plate. Buffer alone was used as blank. P-Rhod (5 μM) was added
to all wells using an automatic injector, and fluorescence changes were
recorded at excitation of 480 nm and emission of 520 nm using a multimode
plate reader (FLUOstar Omega; BMG Labtech). Data are reported as per-
centage increases compared with background signal (blank).
Nitrous Oxide Quantification by GC. Stock solutions of DEA/NO (10–200 μM)
were mixed with Na2S (100 μM) in phosphate buffer, injected into a 10-mL
round-bottom flask sealed with a rubber septum, flushed with either N2 or
air, and incubated at 37 °C, and at the indicated time points, headspace
aliquots (100 μL) were injected through a gas-tight syringe onto a 7890 A
Agilent Gas Chromatograph equipped with a microelectron capture de-
tector and a 30 × 0.32-m (25 μm) HP-MOLSIV Capillary Column. The retention
time of nitrous oxide was 3.4 min, and yields were calculated based on a
standard curve for nitrous oxide (Matheson Tri-Gas). Angeli’s salt was used
as the reference compound for HNO. In some experiments, 200 μM triar-
ylphosphine was used to trap HNO.
Statistical Analysis. Data are reported as means ± SEMs. ANOVA followed
by an appropriate posthoc multiple comparison test was used to test for
statistical significance.
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 2 
SI : Chemical Reactions 
Reaction of sulfide with RSNO 
As discussed previously (1), the reaction of excess sulfide with nitrosothiols (RSNO) mainly 
occurs via direct transnitrosation reaction and formation of thionitrite (SNO-); its protonated 
form, thionitrous acid (HSNO) can react with a second HS- leading to the formation of the 
more stable intermediate SSNO-.  
   RSNO + HS(S)-  RSH + SSNO-     [1] 
We suggest the following model for the formation of SSNO- that is consistent with all our data 
(for simplicity, we here use the protonated forms of all reactants because we do not have pH 
dependent kinetic data to elucidate the contribution of differently charged species): 
   RSNO  +  H2S   RSH  +  HSNO    [2] 
   HSNO  +  H2S   HSSH  +  HNO    [3] 
   HSSH  +  RSNO   HSSNO  +  RSH    [4] 
   HSSH  +  HSNO   HSSNO  +  H2S    [5] 
 
 
Reaction of sulfide with NO!  
Although this reaction was studied a long time ago, the mechanisms involved are not fully 
understood, particularly as far as the reaction between NO and HS- is concerned. 
Early thermodynamic studies proposed that NO and H2S should react to produce water, 
sulfur and nitrogen according to the following stoichiometric equation (4): 
   2NO! + 2H2S 2H2O + 2S + N2     [6] 
However, calculations of this sort can rarely tell whether the reaction occurs or not; this is 
determined by the height of the energy barrier of the reaction profile, which could be 
impossibly high for the reaction of a radical with an anion. Experimental studies - carried out 
mainly under anaerobic conditions in (unbuffered) alkaline aqueous solutions or in polar 
organic solvents- suggested involvement of complex reaction mechanisms as nature and 
yield of the products obtained were strongly dependent on reaction conditions (pH, 
temperature, pO2, solvent), in particular the concentration ratio of the reagents (5-8).  
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Since NO itself is not a very efficient nitrosating agent the question arises as to how it can 
react with HS-. We propose 3 mechanisms involving: 1. prior oxidation of NO, 2. oxidation of 
HS-, 3. direct reaction with formation of a radical intermediate. 
1. NO is oxidized to N2O3, a nitrosating species (aerobic conditions)  
The simplest assumption is that under aerobic conditions sulfide is nitrosated by reaction 
products of the NO autoxidation reaction in which NO is first oxidized to N2O3 which leads to 
formation of SNO-; the latter reacts with excess sulfide as described above. 
   2 NO! + 1/2 O2  N2O3      [7] 
   HS- + N2O3  HSNO + NO2-     [8] 
However, our results with DEA/NO and aqueous NO solution (Fig. 1A,B, main text), and 
previous literature (5, 7) clearly demonstrate that the reaction also occurs (to about the same 
extent) under strict exclusion of oxygen, rendering this an unlikely route of formation.  
2. Sulfide undergoes a 1-electron oxidation to form sulfur radicals reacting with NO! 
The 1-electron oxidation of sulfide leads to formation of thiyl radicals (HS!), which rapidly 
react to form HSS!-, as well as SO! and SO2! radicals (9, 10). These radicals may intercept 
co-generated NO! to form HSNO (see Reaction 26 underneath).  
   HS-  HS! + 1 e_      [9] 
The pKa value of HS! is not known but suspected to be smaller than 7 (9). Therefore, at 
physiological pH the radical anion S!- will be the major reactive form (9). 
   HS! S!- + H+         [10] 
The S!- radical can either dimerise (Reaction 11) or react by addition to HS- (Reactions 12-
13) (9) or O2  (Reaction 14) (10).  
   2 S!-  S22-         [11] 
   S!- + HS-  HSS!2- + H+ HS2-   [12] 
   S!- + HS2-  HSS!2-  + HS-     [13] 
   S!- + O2 [SOO!-]  SO2!-     [14] 
HS! and HSS!2- radicals may be formed  
a. by direct reaction with molecular oxygen (not very efficient); 
    HS- + O2  S!- + H+ + O2!-     [15] 
b. by transition metal (e.g. copper or iron) catalysis;  
   Cu(II) + HS-  Cu(I) + HS!     [16] 
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Copper ions, for example, may be present even in very pure aqueous buffers and have been 
shown to participate in chemical reactions even while complexed with metal chelators (11).  
c. by homolytic cleavage of long-chain polysulfides (HSn-)  
   S42-  2 S2!-        [17] 
    S52-  S2!- + S3!-       [18] 
   2 S52-  S2!- + S8 ↓      [19] 
This process may be transition metal catalyzed, and polysulfide will reduce transition metals 
in 1-electron processes (12). The presence of long-chain HSn- cannot be fully excluded from 
sodium sulfide stocks. A difficulty with such a mechanism is that sulfur tends to polymerize, 
and the driving force for the decomposition of polysulfides to anion radicals is not clear.   
d. by homolytic cleavage of HSNO (or its isomers), or SSNO-, once formed by other routes. 
The mobile hydrogen of HSNO allows isomerisation of HSNO (1, 13-15) by a facile cyclic 1,3 
shift.  
                     [20] 
   HNSO  HOSN  HSNO  HONS   [21] 
HSNO and its isomeric forms, as well as SSNO- can homolyse to generate NO and thiyl 
readicals  
   HSNO  HS! + !NO        [22] 
   SSNO-  SS!-+ !NO      [23] 
3. Direct reaction of NO with sulfide may form SNOH! radicals 
In attempts to explain the direct nitrosation of GSH by NO under anoxic conditions, formation 
of an intermediate radical, GSNOH! has been proposed recently (16, 17). This radical would 
donate the electron to an electron acceptor, forming the nitrosothiol. 
   NO! + GSH  [G-S-N!-OH]  GSNO + 1 e- + H+ [24] 
In analogy an intermediate radical may be formed and undergo condensation reactions with 
other radicals forming S/N hybrid species.  
   NO! + HS-  [SNOH!-]      [25] 
This possibility remains speculative. 
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Formation and decomposition of HSNO and HSSNO  
Generated S!- and S2!- (according to reactions 9-19; 22,23) can react directly with NO to 
form HSNO and HSSNO.  
    HS! + NO!  HSNO      [26] 
    HS2! + NO!  HSSNO      [27] 
HSNO and SSNO- can undergo homolytic cleavage (HSS!- and NO!) according to reactions 
22 and 23; HSSNO can be formed also via transnitrosation of HSNO (Reaction 5). 
As observed by Seel (6, 18), under non-aqueous anaerobic conditions there is an equilibrium 
between HSSNO and the blue trisulfide radical (S3!-), depending on the presence of NO in 
the gas phase. According to Seel (18) this is due to an equilibrium between HSSNO and 
disulfide (inverse reaction 27). The latter leads to formation of the more stable trisulfide and 
tetrasulfide anion radicals (see below reactions 28,29,and 30), which can be observed by 
UV-Vis and/or EPR, respectively (18).    
     
Formation and decomposition of polysulfides 
S!- and S2!- generated from sulfide (according to reactions 9-19) or from decomposition of 
HSNO or SSNO- (according to reactions 22, 23), can react with one another leading to 
formation of polysulfides. 
  S!- + S2!-  S3 2-             [28]
  S!- + S3 2- + H+  S3!- + HS-       [29]
  S!- + S42- + H+  S5!- + HS-       [30]
  2 S2!-  S42-  Sn2-  S(n-1)2- + H2S    [31] 
Polysulfides are formed during SSNO- decomposition, but do not affect its kinetics of 
decomposition since decay was similar in the presence and absence of CN- (SI Fig. S5). As 
expected, sulfur is extruded on addition of acid, and can be quantified by chloroform 
extraction (SI Fig. S5). 
Formed polysulfide may undergo further reactions including: a) polymerization reaction to 
longer chain polysulfides (reaction 31) and inorganic sulfur (reaction 19); b) decomposition to 
sulfide in the presence of strong nucleophiles (such as thiolate and cyanide), a property we 
used in the present study to distinguish them from SSNO-; c) homolytic cleavage (see 
reactions 17-19).  
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Formation and decomposition of SULFI/NO 
A potential precursor in the formation of SULFI/NO from NO and sulfide is sulfite (SO32-), as 
suggested by others earlier, not only for the reaction of sulfide with NO under anoxic 
conditions (5, 7), but also for explaining the formation of SULFI/NO by the reaction of NO 
with thiosulfate (S2O32-) and dithionite anion (S2O42- )(7).  
    HSO3- + 2 NO!  N(O)N(OH)SO3-   [32] 
In aqueous solution, sulfite may be formed either by reaction of sulfide with molecular oxygen 
(O2)(19) or via formation of radical intermediates such as SO2!- (described in reaction 14). 
The SO2!- radical anions are identical to those obtained by dissociation of dithionite S2O42- 
anion (9).  
    2SO2! -   S2O42-      [33] 
The latter is known to react rapidly with O2 and sulfide, leading to formation of SO32- and 
S2O32-. Moreover, the S2O42- anion is known to reduce polythionate to SO32-, S2O32-. and S8 (9, 
20). 
Alternatively, SO32- is formed via hydrolysis of intermediate HONS, formed by isomerization 
of HSNO to thiosulfate as proposed by Goehring et al. (13): 
    HONS + 2 H2O  HONH2 + S (OH)2   [34] 
    2 S(OH)2  S2O32- + H2O + 2H+   [35] 
    S2O32- + H+  HSO3- + S8     [36] 
Since no SO32- was detected by HR-ESI-MS in freshly prepared sulfide stock solutions, and 
sulfide autoxidation is a rather slow process, production of S2O32- via radical reactions and/or 
via HONS/HSNO would appear to be the most plausible route.  
Decomposition of SULFI/NO leads to formation of SO32-, sulfate (SO42-) and nitrous oxide 
(N2O). While it has been proposed that this process occurs directly (21), the formation of both 
HNO and NO from hyponitrite (ON:NOH-) has been proposed by others (22-24).  
    O=NN(OH)-SO3-  N2O +H2SO4   [37] 
    O=NN(OH)-SO3- + H2O  ON:NOH- + H2SO4.  [38] 
Indeed, evidence for trace levels of ON:NOH- in incubation mixtures of both SULFI/NO and 
DEA/NO (but not SNAP) with sulfide were observed by us using HR-ESI-MS (SI Fig. S8); in 
addition, sodium hyponitrite was found to release NO at pH 7.4 as detected by gas phase 
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chemiluminescence, and its release was markedly enhanced in the presence of the 1-
electron oxidant ferricyanide, consistent with the generation of HNO (25).  
ON:NOH- is known to decompose to N2O and water via intermediate formation of HNO:NOH. 
   NO:NOH- + H+  HNO:NOH  N2O +H2O  [39] 
In addition, nitroxyl can be reduced by sulfide to hydroxylamine (NH2OH) and then be 
nitrosated. The latter was found to occur by Bagster et al. in the reaction of NO with sulfide 
(8). 
 
Parallel reactions 
Alternatively, direct reaction of NO with polysulfides with subsequent formation of nitroxyl 
may be involved. In analogy to sulfhydryl radicals (26), polysulfides and persulfides have 
recently been proposed to be better radical reducing/capturing reagents compared to sulfide 
itself (because of resonance stabilization of the generated radical species by the adjacent 
sulfur atoms)(12) and hence they might be able to directly reduce NO: 
   HSSH  + NO!   HSS!  +  HNO    [40] 
   HSS!  + HS-    HSSSH!-       [41] 
   HSSSH!-  + O2    HSSSH  +  O2!-     [42] 
   O2!- + NO!      ONOO-      [43] 
Reactions 42 and 43 are known to be close to the diffusion controlled limit, and peroxynitrite 
is a powerful oxidant (27, 28).  
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SI : Materials and Methods  
Materials. The potassium salt of N-nitrosohydroxylamine-N-sulfonate (SULFI/NO) was 
synthesized as described by Drago et al.(29) and found to release 1.03 mol of N2O per mol of 
compound as measured by gas chromatography with electron capture detection (Shimadzu 
GC-2014). S-nitroso-N-acetyl-D,L-penicillamine (SNAP) was either prepared as described by 
Field et al (30) or in situ by nitrosation of N-acetyl-D,L-penicillamine with acidified nitrite (see 
below). Ultrapure water was generated using a Milli-Q system (Millipore), 3-isobutyl-1-
methylxanthine (IBMX) and Angeli's salt were from Cayman Chemicals (Biomol, Hamburg, 
Germany), DETA/NO and DEA/NO from Alexis (Enzo Life Sciences, Exeter, UK). Unless 
otherwise specified, all other chemicals were of the highest purity available and purchased 
from Sigma-Aldrich (Schnelldorf, Germany or Gillingham, UK), cell culture plastics from 
Greiner (Frickenhausen, Germany), and other cell culture material from PAA (Pashing, 
Austria). Fetal bovine serum (FBS) was from Cambrex (Lonza, Cologne, Germany).  
 
Cell culture. Rat fibroblastoid-like (RFL-6, ATCC CCL192™) cells were purchased from 
LGC Standards GmbH (Wesel, Germany) and cultured from passage 8-18 in T9 flasks using 
RPMI 1640, supplemented with 20% fetal bovine serum and antibiotics in a CO2 incubator 
under standard cell culture conditions.  
 
Animals. All experiments were performed following local ethics committee approval by either 
the Institutional Animal Care and Use Committee (IACUC) at Boston University School of 
Medicine (Boston, MA), University College London (London, UK), or the State Veterinary and 
Food Administration of the Slovak Republic. Animals were handled in accordance with the 
Guide for the Care and Use of Laboratory Animals published by the US National Institutes of 
Health (NIH publication no. 85-23, revised 1996) and Home Office (UK) guidelines under the 
1986 Scientific Procedures Act. Male Wistar rats (270-325 g, Charles River) were kept on a 
normal 12/12 light cycle and allowed to acclimatize to local vivarium conditions for at least 7 
days prior to experimental use.   
 
Preparation of stock solutions SSNO-, and polysulfide containing mixtures. Stock 
solutions of SNAP (100 mM, DMSO) and IBMX (50 mM, DMSO) were kept aliquoted at -
20°C until use. Stock solutions of DEA/NO, DETA/NO, Sper/NO, SULFI/NO and Angeli's salt 
were freshly prepared in 0.01 M NaOH, diluted in PBS and used immediately. Stock 
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solutions of S-nitrosocysteine (CysNO), 15N-SNAP, SNAP, and S-nitrosoglutathione (GSNO) 
in aqueous solution were freshly prepared either from crystalline material or via reaction of 
the reduced thiols with acidified nitrite (31) and used immediately. Saturated aqueous 
solutions of NO were prepared as described (32), kept sealed with minimal headspace under 
argon and used without further dilution; aliquots of this stock were directly transferred into 
cuvettes using argon-flushed Hamilton syringes. For in vitro and cell culture experiments 
Na2S stock solutions (200 mM, anhydrous, Sigma-Aldrich) were prepared fresh before each 
experiment by dissolving anhydrous Na2S in a strong buffer (1 M TRIS or phosphate buffer, 
pH 7.4) and diluted further in 100 mM TRIS or 50-100 mM phosphate buffer pH 7.4 
immediately before use. For in vivo experiments NaHS stock solutions were prepared in 300 
mM phosphate buffer pH 7.4, diluted in phosphate buffered saline (PBS) pH 7.4 and used 
immediately (10 mg/ml = 176.7 mM NaHS; anhydrous; Alfa Aesar; Heysham, UK). In near-
neutral aqueous solution both Na2S and NaHS will rapidly dissolve to S22- and HS-, 
respectively, and undergo protonation according to the following equilibrium (mean pKa1 = 7; 
pKa2 >12) (33). 
   S22- HS- H2S (aq) H2S (g)   [44] 
Therefore, at pH 7.4 both salts will give a solution mainly containing HS- with only negligible 
amounts of S22-, but a stronger buffer is needed to adjust the pH of Na2S to physiological pH.  
It is important to point out that the relative amounts of the three species at equilibrium 
depend on temperature, pH, ionic strength, amount of H2S gas leaving the solution, as well 
as “side” reactions including sulfide oxidation to form sulfite, sulfate, and thiosulfate, and 
polymerization reactions generating polysulfides (33). Although all precautions were 
undertaken to avoid the presence of such contaminants, their presence in the stock solutions 
cannot be excluded. The presence of those species may even initiate some of the chemistry 
leading to observed products. Nitrosopersulfide (SSNO-) enriched mixtures (‘SSNO- mix’) 
were obtained by adding appropriate volumes of the stock solutions directly to the incubation 
buffer to achieve final concentrations of 0.5-3 mM for SNAP or DEA/NO and 0.2–10 mM for 
sulfide and incubated for 1-10 min, as appropriate. Where indicated, excess sulfide was 
removed by purging solutions with Ar or N2 for 10 min; the formation of SSNO- and the 
removal of sulfide were verified spectrophotometrically. For in vitro and in vivo bioactivity 
experiments, stock solutions of SSNO- were prepared by reacting 1 mM SNAP with 10 mM 
Na2S in 1 ml PBS or TRIS 100 mM pH 7.4 and incubating for 10 min. The (theoretical) 
maximal yield of SSNO- under these conditions is 1 mM, corresponding to the concentration 
of added nitrosothiol (please refer to Fig. S9 for experimental determination of reaction yield).  
In a typical experiment, 10 µl of SNAP (100 mM/DMSO) and 100 µl Na2S (100 mM/Tris 100 
mM pH 7.4) stock solutions were added to an amber centrifugation tube containing 890 µl 
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Tris 100 mM pH 7.4. After 10 min of incubation at RT, excess sulfide was removed by 10 min 
bubbling with N2. For cell culture experiments 20 µl of this mix was then added to cell culture 
medium of a total volume of 1 ml (corresponding to a 1:50 dilution) to yield a final 
concentration of 20 µM SSNO-. For in vivo experiments the SSNO- solution was prepared in 
phosphate buffer pH 7.4, and further diluted in PBS to obtain the doses indicated for bolus i.v 
injection (dose range 0.03 -3 µmol/kg) or used directly for continuous i.v. infusion (0.16 
µmol/kg/min). Mixtures of polysulfides were prepared by oxidation of sulfide with HOCl as 
described (34, 35). Briefly, 500 µl of 20 mM HOCl was added dropwise to 500 µl of 120 mM 
Na2S upon continuous vortexing. Then, 600 µl of this solution were diluted by addition of 300 
µl H2O and 100 µl of 9% NaCl. To allow direct comparison, a sulfide solution was prepared 
under identical conditions by adding 200 µl of 120 mM Na2S solution to 700 µl H2O and 100 
µl 9% NaCl.    
 
Effects of sulfide, SSNO-, SULFI/NO and polysulfides on cardiovascular 
hemodynamics. All procedures were conducted in male Wistar rats anesthetized with 2% 
isoflurane, as described (36). Briefly, the effects of bolus intravenous injection (i.v.) of 
increasing doses of NaHS (doses range 0.1 -1 mg/kg = 1.8 - 17.7 mg/kg in PBS), or SSNO- 
mix (dose range 0.03 -3 µmol/kg in PBS), or vehicle control (PBS only) , or SULFI/NO (stock 
10 mM in 10 mM NaOH/ NaCl 0.9%, injected at dose range 0.03 -3 µmol/kg), or vehicle 
control (dose range 0.03 -3 µmol NaOH/kg in 0.9%NaCl) on cardiovascular hemodynamics 
and circulating NO stores were assessed at 10 min intervals. Continuous infusion of either 
NaHS (1 mg/ml = 17.7 mM in PBS pH 7.4) or SSNO- (1 mM in PBS pH 7.4) or PBS only, or 
SULFI/NO (1 mM in 0.25 mM NaOH/NaCl 0.9%) or vehicle control (0.25 mM NaOH/NaCl 
0.9%) were administered at a rate of 10 ml/kg/h via a right internal jugular venous line. Final 
doses were 2.94 µmol/kg/min for NaHS, 0.16 µmol/kg/min for SSNO-, and 0.16 µmol/kg/min 
SULFI/NO (in 25 mM NaOH/0.9% NaCl with 4.16 µmol NaOH/kg/min for the vehicle control). 
Continuous monitoring of mean arterial pressure (MAP) and blood withdrawal were 
performed from an indwelling arterial (left common carotid) line. Blood was taken at defined 
time points (0, 5, 10, 30, 60, 120 minutes) and processed as previously described for 
determination of NO metabolites by chemiluminescence (37). Cardiac function and heart rate 
were assessed by transthoracic echocardiography using a Vivid 7 device (GE Healthcare, 
Bedford, UK) as described (36). A rectal probe (TES Electrical Electronic Corp., Taiwan) 
inserted 3 cm in depth was used to measure core temperature. The hemodynamic effects of 
polysulfides were assessed by injecting 150 µl polysulfides/sulfide mixture (stock 6 mM HSx-/ 
24 mM HS- in NaCl 0.9%) or sulfide alone as a control (24 mM HS- in NaCl 0.9%) 
corresponding to doses of ≈ 2.7 µmol/kg HSx- and 10.8 µmol/kg, respectively (35). Other 
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doses were obtained by 1:2 and 1:6 dilution and were 0.45 µmol/kg HSx- / 1.8 µmol/kg HS- 
and 1.35 µmol/kg HSx- / 5.4 µmol/kg HS-.   
  
Determination of circulating NO stores. Blood was anti-coagulated with EDTA (2.5 mM), 
and N-ethylmaleimide (NEM, 10 mM) was added to prevent artificial thiol nitrosation and 
minimize anion exchange processes across blood cell membranes. Plasma and erythrocytic 
fractions were obtained by centrifugation at 800xg at 4°C for 10 min. Once separated, 
samples were frozen with liquid N2 and kept at -80°C for later NO metabolite analyses, as 
described (37). Plasma was harvested as described above, thawed, and analyzed.  After 
thawing, erythrocytes were subjected to hypotonic lysis in 4 volumes of a solution of NEM 
(10 mM) and EDTA (2.5 mM) in water prior to analyses. In both blood compartments, NO 
oxidation products (nitrite and nitrate) were quantified using HPLC ion chromatography 
(ENO-20, Eicom). Plasma and erythrocytic nitrosation products (RXNO) and erythrocytic 
nitrosylation products (NO-heme) were measured by gas phase chemiluminescence (CLD 
77am/sp, Eco Physics AG, Dürnten, Switzerland).   
 
Effects of sulfide on NO bioactivity, and detection of NO release and bioactivity of 
SSNO- and SULFI/NO in RFL-6 cells. The effects of sulfide on Sper/NO mediated activation 
of sGC were determined by measuring changes in intracellular cGMP levels in RFL-6 cells in 
response to 100 µM Sper/NO in the absence or presence of increasing concentrations of 
sulfide (1 µM, 10 µM and 100 µM Na2S in Tris 100 mM pH 7.4) as described (1), with minor 
modifications. Briefly, 1.5 x 105 RFL-6 cells were seeded on 6-well plates and grown to 
confluence for 48 hours in complete RPMI 1640 growth medium containing 20% FCS 
(complete medium), washed with PBS, and pre-treated for 15 min with 500 µM IBMX in 1 ml 
complete medium without serum (treatment medium) to inhibit PDE activity. The medium 
was removed, and fresh treatment medium was added (1 ml/well).  Sulfide treatments were 
added directly to the culture medium, immediately (< 1 min) followed by addition of Sper/NO. 
Cells were incubated for 20 min, washed with cold PBS and lysed in 0.1M HCl for 20 min at 
room temperature (RT). The incubation time and the concentration of the NO donor were 
carefully optimized in preliminary experiments by testing 10 and 100 µM Sper/NO, and 
incubating cells for time intervals between 1 and 30 min. The NO/HNO bioactivity of SSNO- 
and SULFI/NO were compared by treating IBMX-pretreated cells (as above) with 20 µM 
SSNO- mix, with 1 µM, 10 µM and 100 µM SULFI/NO, or with 1 µM, 10 µM and 100 µM of 
the HNO donor Angeli's salt for 20 min. In some experiments, ~7000 U/ml SOD (stock 10 
mg/ml in PBS pH 7.4, specific activity 4557 U/mg) was added directly to the treatment 
medium 5 min before addition of SSNO- mix, SULFI/NO or Angeli's salt to enable 
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extracellular conversion of HNO into NO. In selected experiments, an sGC inhibitor (ODQ, 50 
µM), an NO scavenger (cPTIO, 500 µM) or a nitroxyl scavenger (1 mM Cys) were added 5 
min prior to the other treatments. Intracellular cGMP levels were assessed in cell lysates by 
using DetectX®High Sensitivity Direct Cyclic GMP kit by Arbor Assay (Biotrend, Cologne, 
Germany) as per manufacturer’s instructions. Protein concentrations in the supernatant were 
determined by a modified Bradford’s protein assay (Roti-Nanoquant, Carl Roth GmbH + Co. 
KG, Karlsruhe, Germany) after pH equilibration with 200 mM TRIS pH 8.  Data were 
normalized for protein content and expressed as folds of untreated control to further account 
for the variability in basal cGMP levels of RFL-6 cells of different batches and passages. 
 
Time-resolved NO detection, NO trapping and NO release by chemiluminescence. 
Time-resolved detection of NO release from DEA/NO, Sper/NO, GSNO and SNAP and their 
reaction mixtures, was carried out by gas phase chemiluminescence detection (CLD 77am 
sp) using a custom-designed, water jacketed glass reaction chamber (15 ml total volume) 
kept at 25±0.1°C using a circulating water bath and continuously bubbled with N2, essentially 
as described (1). 
NO trapping by sulfide, sulfite and thiosulfate was monitored as described above, with NO 
generated using a slow-releasing NO-donor (DETA/NO).  Briefly, DETA/NO was injected 
from a concentrated alkaline stock solution into the reaction chamber containing buffer to 
achieve a final concentration of 33.4 µM; after NO release reached a steady-state, this was 
followed by injection of 33.4 and 334 µM of Na2S, or 664 µM of Na2SO3, Na2SO4, and 
Na2S2O3.  
NO formation from SSNO- enriched mixtures, in the presence or absence of the metal 
chelator DTPA (100 µM), in 1 M Tris/HCl or 100 mM phosphate buffer pH 7.4 was monitored 
by chemiluminescence detection as described above. Briefly, 1 ml volumes of the respective 
SNAP/sulfide mixtures were pre-mixed in Eppendorff vials, vortexed, and after 1 min of 
incubation a 150 µl aliquot of the reaction mixture was transferred into the reaction chamber 
containing 15 ml buffer (dilution 1 : 100) by means of a gas-tight syringe. NO concentration in 
the sample gas was recorded continuously and peak areas were integrated using an EPC-
500/PowerChrom data processing system (eDAQ). 
 
Determination of reaction kinetics by UV-visible spectroscopy. The spectroscopic and 
kinetic behavior of the reaction between sulfide and DEA/NO, Sper/NO, GSNO and SNAP 
was followed by rapid scanning UV-visible spectroscopy in 3 ml quartz cuvettes, kept at 
either 25.0 or 37.0±0.02°C with continuous stirring (t2 peltier-type cuvette holder with TC1 
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temperature controller, Quantum Northwest, Liberty Lake, WA) using a Cary 60 UV/Vis 
spectrophotometer and analyzed using WinUV software (Agilent Technologies, Wokingham, 
UK) as described (1). No differences in spectral changes were observed whether reactions 
were carried out in the presence or absence of DTPA (100 µM), suggesting that transition 
metal contamination of our buffers was negligible. 
 
High-resolution mass spectrometry for detection of SSNO-, polysulfides and 
SULFI/NO. High-resolution mass spectrometry (HRMS) was conducted using an LTQ 
Orbitrap XL hybrid linear ion trap-orbitrap mass spectrometer equipped with a nanospray 
ionization source (Thermo-Fisher, Hemel Hempstead, UK). Sample mixtures were prepared 
as described above except that all final incubations were carried out in 50 mM ammonium 
phosphate buffer pH 7.4; reaction mixtures were prepared on-site and infused directly into 
the ion source using a gas-tight glass syringe and peek tubing. Acetonitrile (HPLC grade, 
Fisher Scientific Ltd, Loughborough, UK) was used as make-up solvent and mixed with the 
reaction solutions at a ratio of 1:5 via a T-piece to improve ionization efficiency. The 
instrument was controlled with XCalibur 2.1 (Thermo-Fisher). Spectra were acquired in 
negative ion mode with a spray voltage of 5 kV and nitrogen as sheath gas; capillary 
temperature was set at 300°C, and capillary voltage at 20 V. Instrument parameters, 
especially those of the ion optics, were optimized for each individual compound of interest. 
Elemental analysis, based on accurate mass and a priori information of likely elemental 
composition, and isotope distribution simulation were performed using XCalibur 2.1. 
 
Electrospray ionization high-resolution mass spectrometry for HSNO detection. All 
experiments were carried out using a maXis Impact instrument (Bruker Daltonik GmbH, 
Bremen, Germany) operating in positive ionization mode (ESI+; capillary voltage 4700 V, dry 
gas flow and temperature 4.0 L/min, 180°C; scan 30-500 m/z). The instrument was calibrated 
in the mass range of 45-156 using a mixture of low-mass calibrants and found to perform at a 
mass accuracy of 1-2 ppm using Li-formate clusters. In some experiments ESI+ was carried 
out at lower temperatures (4° or -20°C) using a Bruker Cryospray unit, with and without 
acetonitrile or methanol (1:1-1:4) to enhance ionization efficiency using an infusion rate of 
240 µl/h. 
GSNO and SNAP stock solutions were prepared approximately 1h ahead of the experiments 
by mixing equal volumes of equimolar solutions of the corresponding reduced thiols (L-
glutathione and N-acetyl-D,L-penicillamine) in 1N HCl with aqueous sodium nitrite (or 15N-
nitrite) to produce a 10 mM GSNO (pink) and 2 mM SNAP (green) stock solution which was 
kept on ice in the dark. These stocks were diluted 1:5 in ice-cold 1N (NH3)3PO4 pH 7.4 
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immediately before each incubation run. Sulfide stock solutions were prepared anaerobically 
in 1 M (NH4)3PO4 buffer pH 7.40 from Na2S and kept under argon. Incubations were carried 
out at pH 7.4 / RT in 10 mM ammonium phosphate buffer under the following conditions: 
GSNO 1 mM, Na2S 1 or 8 mM; SNAP 0.2 mM, Na2S 0.2 mM, with final buffer concentrations 
varying between 50 and 500 mM. Nitrosothiol solutions and reaction mixtures were infused at 
a rate of 4 µL/min directly into the electrospray source and spectra were recorded for up to 
10 min. 
 
Determination of sulfide release from SSNO- by the methylene blue method. An SSNO- 
mix was prepared by incubating 500 µM SNAP and 5 mM H2S in 175 mM Tris/HCl buffer 
containing 87.5 µM DTPA (pH 7.4). After 5 min of incubation at RT (necessary to complete 
SSNO– formation), 5 mM DTT (or H2O in the control) was added to the samples. To ensure 
the assay only measures sulfide that is released by SSNO-, polysulfides (which also form in 
the reaction of SNAP with sulfide) were reduced by DTT to H2S, which was subsequently 
eliminated from reaction mixtures by bubbling with Ar. When polysulfide reduction by DTT 
was completed (10 min) the system was bubbled with Ar for 30 min (>98% of polysulfides 
and H2S is removed by this method before substantial SSNO- decomposition). This was 
followed by the addition of another 5 mM DTT aliquot, and the pH was raised to 9.3 by 
addition of 100 mM NH4OH. The reaction mixture was kept in the dark to avoid photolytic 
decomposition reactions. The amount of sulfide that was released by SSNO‒ decomposition 
from this reaction mixture was measured by the methylene blue method (into 500 µL of 10x 
diluted sample, 250 µL of 54.7 mM zinc acetate, 133 µL of 31.6 mM DPD (N,N-dimethyl-p-
phenylenediamine, sulfate salt) in 7.2 M HCl and 133 µL of 18 mM FeCl3•6H2O in 1.2 M HCl 
were added).  After 15 min incubation at RT, sulfide content was quantified 
spectrophotometrically at 670 nm with the aid of a calibration curve that was constructed 
using authentic sulfide standards. The presence of DTT had no effect on the assay. 
 
Determination of polysulfides by the cold cyanolysis method. Sample preparation was 
as described under the Methylene blue method section above except that DTT addition was 
excluded from this protocol. After Ar bubbling and raising the pH to 9.3, 55 mM KCN was 
added to the reaction mixture (which was again stored in the dark). Polysulfide content was 
quantified at the indicated time points by adding 15 µL of 37% formaldehyde and 150 µL of 
Goldstein reagent (62 mM FeCl3•6H2O in 18.4% HNO3) into a 675 µL sample aliquot (that 
was incubated with KCN). Quantification was based on the measured absorbance values at 
460 nm following 15 min incubation at RT with the reagent solutions. A baseline correction 
was applied by subtracting the spectrum of the starting solution, which was measured after 
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eliminating polysulfides and sulfide from the reaction mixture (by adding 500 µM DTT 
followed by Ar bubbling at pH 7.4 before the pH jump to 9.3) before substantial SSNO‒ 
decomposition occurred. Calibration curves were developed using standard KSCN solutions. 
Polysulfides that were generated in the reaction of SNAP with sulfide were quantified by 
incubating the reaction mixture for 10 min only with cyanide before the addition of 
formaldehyde and the Goldstein reagent. In independent experiments we verified that (under 
similar conditions) 10 min was enough to have >90% of the polysulfides reacting with 
cyanide. The amount of sulfane sulfur that was released during SSNO‒ decomposition was 
quantified by subtracting the polysulfide content that is not originating from SSNO‒ from the 
total amount of the measured sulfane sulfur after complete decomposition of SSNO‒. 
 
Determination of sulfane sulfur by extraction into chloroform. The amounts of 
polysulfides other than SSNO– that were generated in the reaction of SNAP with sulfide and 
the amount of sulfane sulfur that forms upon the decomposition of SSNO– were also 
quantified spectrophotometrically after extraction of sulfane sulfur into chloroform. A 
SNAP/sulfide (1:10 molar ratio) reaction mixture was prepared by mixing 500 µM SNAP with 
5 mM H2S in DTPA-contaning Tris/HCl buffer pH 7.4 as described above. However, this 
mixture was not bubbled with Ar and the pH was not adjusted to 9.3. Two volume equivalents 
of chloroform were added to the reaction mixtures immediately upon completion of SSNO- 
formation (5 min after mixing SNAP with sulfide) or at 540 min (i.e. after complete 
decomposition of SSNO-). Extraction was achieved by 30 min vortexing of the 
heterogeneous mixture. Sulfane sulfur content of the organic phase after the extraction was 
quantified spectrophotometrically at 280 nm based on a calibration curve (repeated 3x) that 
was developed by dissolution of known amounts of authentic cyclo-octasulfur; this gave us 
an extinction coefficient for sulfur of 925.9 M-1 cm-1 at 280 nm. 	  
Nitroxyl detection by metHb trapping. Trapping of HNO by methemoglobin (metHb) with 
subsequent formation of HbNO following reductive nitrosylation was assessed as increase in 
absorbance at 542 nm and 583 nm of a solution of 10 mg/ml in Tris Buffer 1M pH 7.4 (100 
µl) treated with 1-100 µl of 50 mM Angeli’s salt in 0.01 M NaOH or an NO/sulfide reaction 
mixture, respectively. Control incubations were carried out with metHb and sulfide alone. 
 
Nitroxyl detection by P-Rhod fluorescence. Nitroxyl formation was assessed also using 
the nitroxyl-specific fluorescence probe P-Rhod (38). Stock solutions of P-Rhod (50 mM in 
DMSO) were aliquoted and kept at -20°C. N2 gassed SSNO- mix (1 mM SNAP/ 10 mM Na2S 
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in Tris 100 mM pH 7.4), SULFI/NO (1 mM in Tris 100 mM), or Angeli's salt (1 mM in Tris 100 
mM) were serially diluted in Tris/HCl 100 mM in a dark 96 well plate. Buffer alone was used 
as blank. P-Rhod (5 µM) was added to all wells using an automatic injector and fluorescence 
changes were recorded at ex 480 nm, em 520 nm using a multi-mode plate reader 
(FLUOstar Omega, BMG Labtech, Offenburg, Germany). Data are reported as percent 
increases compared to background signal.  
 
Nitrous oxide quantification by gas chromatography. Stock solutions of NO 
donors/RSNOs were mixed with Na2S in phosphate buffer and injected into a 10 mL round 
bottom flask sealed with a rubber septum. Angeli’s salt (NaN2O3) was used as reference 
compound for HNO generation. To some air-treated samples 200 µM TXPTS in phosphate 
buffer (10 mM, pH 7.4) was added to trap HNO. Incubation vials were flushed with either N2 
or air, incubated at 37°C, and at the indicated time points headspace aliquots (100 µl) were 
injected via a gas-tight syringe onto a 7890A Agilent gas chromatograph equipped with a 
micro-electron capture detector (µECD) and a 30 m × 0.32 m (25 µm) HP-MOLSIV capillary 
column as described (39). The oven was operated at 200 °C for the duration of the run (4.5 
min). The inlet was held at 250°C and run in split mode (split ratio 1:1) with a total flow (N2 as 
carrier gas) of 4 ml/min and a pressure of 37.9 psi.  The detector was held at 325°C with a 
makeup flow (N2) of 5 ml/min. The retention time of nitrous oxide was 3.4 min, and yields 
were calculated based on a standard curve for nitrous oxide (Matheson Tri-Gas). 
 
Determination of nitrite and nitrate by ion chromatography. An air-equilibrated stock 
solution of SNAP (100 mM) was injected into a septum-sealed glass container containing 50 
mM phosphate buffer (pH 7.4). The formation of nitrite and nitrate over time was monitored at 
5.7 min intervals post mixing (30 s) using high pressure liquid ion chromatography (37).  For 
all mixtures, the final concentration of SNAP was adjusted to 100 µM. SNAP/Sulfide 
incubations (final sulfide concentrations 100 µM and 1000 µM) were prepared by addition of 
appropriate volumes of sulfide from freshly prepared anaerobic stocks (10 mM) to the 
buffered SNAP solution to obtain a final molar concentration ratio of either 1:1 or 1:10 
SNAP:HS- and monitored as above. For all mixtures the total volume was kept constant at 5 
ml.  A 10 µl volume of an air-equilibrated stock solution of 1 mM DEA/NO was injected into a 
septum-sealed container containing 50 mM phosphate buffer (pH 7.4). After 30s of mixing 
the decomposition of DEA/NO was monitored over time using the same intervals and 
methods as described for SNAP above.  For all mixtures, the final DEA/NO concentration 
was 2 µM.  Various concentrations of sulfide (final concentrations 1 µM, 2 µM, 4 µM, and 20 
µM) were individually mixed from freshly prepared stock solutions (100 mM, 10 mM, or 1 
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mM) to the DEA/NO solution to obtain molar ratios of 1:0.5, 1:1, 1:2, and 1:10 DEA/NO:HS-. 
The total volume was kept constant at 5 ml. 
Statistical analysis. If not otherwise described, data are reported as means+/- SEM. 
Statistical significance was tested by using GraphPad Prism 6.0 for Mac OS (GraphPad 
Software Inc.) or with SPSS 22 (IBM). Multiple comparisons were tested with ANOVA 
followed by an appropriate post hoc test as indicated in the figure legends.  Outliers were 
identified graphically by analyzing a box&whiskers plots according to Tuckey. 
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SI : Figure and Legends 
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Figure S1. Association between hemodynamic changes to i.v. bolus application of 
sulfide (dose range 1.8 - 17.8 µmol/kg) and changes in systemic NO status in rats. (A) 
Representative blood pressure tracings in the absence (upper panels) and presence (lower 
panels) of the NOS inhibitor S-ethylisothiourea (SEITU; 1.5 mg/kg/min i.v. infusion) (B) mean 
arterial pressure (MAP) and (C) heart rate (HR) with or without NOS blockade by SEITU. 
(D,E) Levels of nitrite (NO2-), nitrate (NO3-) and total nitroso (RXNO) species in plasma and, 
(along with NO-heme) in red blood cells (RBC); Levels of nitrite, nitrate and nitroso (RXNO) 
species in blood (F,G). Total NO species in plasma (F) and in RBC (G). n = 3; * p<0.05 vs. 
baseline # p<0.05 paired T-Test vs. baseline. 
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Figure S2 
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Figure S2. Continuous i.v. infusion of sulfide (NaHS, dose 2.8 µmol/kg/min) in 
anesthetized rats leads to an initial decrease followed by an increase in NO 
bioavailability. (A) mean arterial pressure (MAP) (B) heart rate (HR). (C,D) Levels of nitrite 
(NO2-), nitrate (NO3-) and total nitroso (RXNO) species in plasma (C) and, along with NO-
heme, in red blood cells (RBC) (D); (E,F) Total NO species in plasma (E) and in RBC (F). 1-
way ANOVA p<0.01; Dunnet * p<0.05; ** p<0.01; ***p<0.001 vs. baseline # p<0.05 T-Test 
between groups.  
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Figure S3 
 
 
 
Figure S3. Sulfite but not thiosulfate and sulfate scavenge NO. Time-resolved 
chemiluminescence recordings of NO release from 33.4 µM DETA/NO in phosphate-buffered 
saline (pH 7.4) after addition of 664 µM sulfite (A) or 664 µM sulfate or 664 µM thiosulfate 
(B); tracings are representative of 3 independent experiments.  
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Figure S4 
 
 
 
Figure S4. Accumulation of SSNO- (λmax 412 nm) in the reaction between DEA/NO and 
sulfide in the presence (aerated) and absence (deaerated) of oxygen. (A,B) The reaction 
between 1 mM DEA/NO with 10 mM Na2S under aerated (A) and deaerated (B) conditions 
was monitored by UV-visible spectrophotometry. (C) Kinetics of accumulation of SSNO- (λmax 
412 nm). (D,E) The reaction between 1 mM DEA/NO with 5 mM Na2S in the presence of 1 
mM polysulfide (Sx2-) from KxSx was monitored under aerated und deaerated conditions. (F) 
The reaction between 1 mM DEA/NO with 2 mM Na2S in the presence of the NO scavenger 
cPTIO does not produce SSNO- (λmax 412 nm). Blue lines depict spectra at start of the 
reaction.
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Figure S5  
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Figure S5. SSNO- is resistant to DTT decomposition and SSNO- contains two sulfur 
atoms one of which is a sulfane sulfur.	  (A,B) Addition of DTT or KCN to the SNAP (500 
µM)/sulfide (5 mM) reaction mixture fully decomposes polysulfide products to H2S (approx 
250 µM sulfide), but leaves SSNO- intact. (A) UV-vis spectra taken in the absence (grey) or 
in the presence of 5 mM dithiothreitol (DTT; orange) at pH 7.4 in TRIS buffer; (B) UV-vis 
spectra in the presence (blue) or in the absence (gray) of potassium cyanide (55 mM KCN 
pH 9.3); (C) the decomposition of SSNO- is not affected by basic pH or by high 
concentrations of dithiothreitol (500 µM DTT) and potassium cyanide (55 mM KCN pH 9.3) (n 
= 3). +Ar –denotes argon gassing for removal of excess sulfide. (D) Release of sulfide from 
polysulfides formed during SSNO- decomposition, as assessed in the presence of 5 mM DTT 
using the Methylene Blue method (n = 3). (E) Determination of sulfane sulfur by extraction 
with CHCl3. Left panel: Schematic representation of the formation of sulfane sulfur 
equivalents by catenation reaction of polysulfide formed during formation of SSNO- 
(Reaction A), and during decomposition of SSNO- (Reaction B).  Center panel:  
Representative spectra of sulfur atoms (i.e. sulfane sulfur equivalents) generated according 
to reactions A and B. Inset: representative standard spectrum. Right panel: Concentration of 
sulfane sulfur equivalents generated in reaction A and B (n = 3), showing that SSNO- 
decomposition accounts for ~30% of the detected sulfane sulfur, while polysulfide 
decomposition account for ~50% of the detected sulfane sulfur. The fact that two times as 
much sulfide (shown in D) as compared to sulfane sulfur (shown in E) was released upon 
SSNO- decomposition corroborates that SSNO- contains two sulfur atoms one of which is a 
sulfane sulfur.  
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Figure S6  
  
 
 
Figure S6. Dinitrosopersulfide and hyponitrite are also formed in the reaction between 
NO/RSNO and sulfide. (A) High resolution mass spectrum of [SS(NO)NOH]- (panel A) 
obtained by the reaction of a 50/50 mixture of 1 mM 14N and 15N- labelled SNAP with 2 mM 
Na2S. (B) High resolution mass spectrum of hyponitrite (ON:NOH-) from 1 mM DEA/NO/ 2 
mM sulfide incubates in ammonium phosphate buffer (10 mM, pH 7.40, RT). The reaction 
solution was analyzed by high-resolution MS using an LTQ OrbiTrap with electrospray 
ionization source operated in negative ion mode. Samples were introduced into the source 
by direct infusion, and acetonitrile was used as make-up solvent to facilitate ionization. 
Representative of 3 independent experiments. 
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Figure S7 
 
 
 
 
Figure S7. Time-resolved chemiluminescence of the generation of NO and HNO from 
hyponitrite.  Hyponitrite  (1 mM , 5 mM or 30 mM, black arrows) decomposes to release NO 
in phosphate buffer (pH 7.4, at 37°C) that reaches a steady-state level after approximately 3 
minutes.  Addition of potassium ferricyanide ([Fe(CH)6]  (red arrows 1.67 mM) 3 min after 
hyponitrite addition potentiates NO release via conversion of HNO into NO. Representative 
of 3 independent experiments.  
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Figure S8 Panel A  
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Figure S8 Panel B  
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Figure S8 Panel C 
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Figure S8. Panel A. Incubations of GSNO (1 mM) with equimolar sulfide produce a very 
small peak at m/z 63.9852 suggestive of the presence of HSNO; two more pronounced 
peaks were present at m/z of 64.0158 and 65.0388 (upper panel). The potential “HSNO 
peak” and the peak at m/z 65 were not observed in the presence of higher sulfide 
concentrations, suggesting the products are thiol sensitive. Importantly, the “HSNO peak” did 
not shift 1 m/z to the right on 15N-labelling of the NO group of GSNO (neither at equimolar 
concentration nor with excess sulfide; 2nd panel). No “HSNO peak” was observed with 
SNAP/sulfide incubations under any reaction condition (shown for SNAP 1mM/sulfide 1 mM 
in panel 3 where SNAP stock solution). Disturbingly, the apparent “HSNO peak” was much 
more prominent on infusion of GSNO or SNAP in the absence of sulfide (lower two panels). 
Very similar results were obtained when electrospray ionization of buffered aqueous reaction 
mixtures was carried out at -20°C. Unexpectedly, neither lower sulfide concentrations (GSNO 
1mM/sulfide 0.3 mM instead of 1:1 or 1:10 ratio) nor lower temperatures increased signal 
intensity of the peak at m/z 63.9852. 
A separate series of experiments was carried out using cryospray ionization in conjunction 
with either acetonitrile or methanol coinfusion in attempts to enhance ionization efficiency 
while minimizing thermolytic cleavage of unstable reaction intermediates. This was 
accomplished by mixing aqueous ammonium phosphate-buffered reaction incubates (kept at 
either RT or 4°C) with the solvents at a ratio of 1:1 or 1:3 (v/v) via a T-piece right in front of 
the sprayer inlet. Panel B depicts results from the series with acetonitrile. GSNO or 15N-
labelled GSNO (both 1 mM) was mixed with substoichiometric (0.3 mM), equimolar (1 mM) 
or excess sulfide (10 mM; incubation solution dark yellow within <30s) and infused 
immediately into the ionization source. Under neither condition any new m/z features 
appeared besides the intense peak for the sodium adduct of acetonitrile at 64.015-64.016, 
which is a common background ion in ESI+ experiments. Panel C depicts the results from 
our subsequent attempts with either SNAP (0.2 mM) or GSNO (1 mM)/sulfide incubations 
and methanol coinfusion showing full scans and the m/z 64 region of interest (insets). 
Spectra are dominated by phosphate and sodium or ammonium adducts of the reaction 
products. Despite an extended wash-out period between experiments the 64 peak originating 
from the acetonitrile used in preceding experiments, albeit now at lower intensity, remained 
the dominating feature in the m/z range of 63-66 with no other peaks being detected during 
any time of the incubation (1-6 min).  
Collectively, these results demonstrate that the apparent “HSNO peak” (m/z 63.9852) reacts 
with excess sulfide, is not particularly temperature-sensitive and quenched on attempts to 
improve ionization efficiency, is generated (presumably within the ion source) from 
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nitrosothiols already in the absence of any added sulfide, but does not originate from the NO 
group of the parent nitrosothiol as it does not shift with 15N-NO labelling.  
Figure S9 
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Fig. S9. The solvent dimethylsulfoxide also produces a peak at m/z 64. 
In earlier experiments we used DMSO to prepare SNAP stock solutions because of its lower 
water solubility compared to GSNO. Accordingly, in positive ionization mode the spectrum of 
incubation mixtures of SNAP and sulfide (A) was dominated by DMSO adducts (arrow 
indicates the blown-up view of the m/z region around 64). B) In those experiments, a peak 
near m/z 64 was observed in SNAP/Sulfide (1:1 and 1:10) incubation mixtures, but not in 
those of DMSO-free GSNO/Sulfide mixtures. A comparison of the theoretical isotope pattern 
for the DMSO fragment (middle panel) and protonated HSNO (lower panel) with the 
experimental data (upper panel; SNAP 1 mM, Na2S 1 mM; pH 7.4, RT; 2-6 min) reveals that 
the 64 peak observed in the SNAP/Sulfide mixture was due to DMSO and not HSNO. C) 
Controls with only DMSO confirmed that the peaks in the region of m/z 63-65 are in fact odd-
electron species originating by loss of CH3/4 and CH4O from DMSO. 
These finding are of relevance to other researchers in this area (in particular when relying on 
multi-user core instruments) as they document that a frequently used solvent known to be 
notorious for sticking to tubings and other surfaces may cause artifactual peaks in the lower 
m/z region around 64, which may originate from remnant material of previous runs. This 
finding adds to the known problems with acetonitrile when working with ESI+ at trace level in 
the m/z region around 64. 
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Figure S10 
 
 
 
 
Figure S10. Detection of nitroxyl release from SSNO- and SULFI/NO as compared to 
Angeli's salt by reductive nitrosylation of metHb and P-Rhod. (A,B) Nitroxyl trapping by 
methemoglobin (metHb) results in an increase in absorbance at 542 nm and 583 nm, as 
shown by reaction of 1 mM Angeli's salt (AS) with metHb in panel A. In panel B production of 
nitroxyl by AS was assessed by reaction with P-Rhod. (C) The ‘SSNO- mix’ (prepared by 
reacting 1 mM SNAP with 5 mM sulfide, followed by removal of excess sulfide gassing the 
solution with N2 increased absorbance at 542 nm and 583 nm. (D) 1 mM SULFI/NO 
increased absorbance at 542 nm and 583 nm to a lesser degree than AS. (E) Sulfide alone 
increases absorbance at 542 nm and 583 nm.  
The use of metHb trapping to test nitroxyl production during the reaction of sulfide with 
nitrogenous species is not reliable, because sulfide reacts with metHb forming a Fe3+-sulfide 
complex (40, 41) with similar absorbance characteristics. 
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Figure S11  
 
 
Figure S11. Release of N2O from SNAP + HS-, GSNO + HS- and Angeli's salt + HS- as 
assessed by gas chromatography. (A,B) Increase in N2O production during formation and 
decomposition of SSNO- and SULFI/NO in the reaction between SNAP and Na2S (A) or 
GSNO with Na2S (B) at the indicated concentrations. (C) N2O released by 50 µM Angeli's 
salt (AS) is decreased by addition of Na2S in a concentration-dependent manner. 
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Figure S12 
 
 
 
 
Figure S12: Polysulfides (HSx–) decrease blood pressure in rats. Intravenous (i.v.) 
administration of polysulfde (2.7 µmol/kg HSx-) / sulfide (10.8 µmol/kg HS-) mixtures obtained 
by in situ oxidation of sulfide (see Materials and Methods and (34)) decrease systolic blood 
pressure (SP), diastolic blood pressure (DP) and mean arterial pressure (MAP) in 
anaesthetized rats. (A,B) Representative traces of effects of i.v. bolus applications of HSx-
/HS- mixture (2.7 µmol/kg HSx-/ 10.8 µmol/kg HS- ) or of sulfide alone (10.8 µmol/kg HS- ) on 
BP. (C) Concentration-dependent effects of the HSx-/HS- mixture (0.45 - 2.7 µmol/kg HSx-/ 
1.8 -10.8 µmol/kg HS- ), as compared to equivalent total amounts of sulfide (1.8 - 10.8 
µmol/kg HS-) on systolic (SP), diastolic (DP) and mean arterial blood pressure (MAP) 
compared to baseline (measurements performed in 8 rats). The magnitude of blood pressure 
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reduction by polysulfides appears to be similar to that of sulfide alone, yet its duration of 
action is prolonged as are duration and magnitude of the reactive pressor effects elicited. 
 
Figure S13 
 
 
 
 
Figure S13: Polysulfides (HSx-) and sulfide modulate arterial stiffness. (a) Both 
polysulfides (2.7 µmoles/kg HSx-/10.8 µmol/kg HS-) and sulfide alone (10.8 µmoles/kg) 
decrease blood pressure in anaesthetized rats. The arrows indicate the point of recording of 
the waveforms (B). Polysulfide and sulfide increase the time delay between the wave 
assessed in the carotic artery (heart, red line) and the tail artery (periphery, blue line) to a 
similar extent. (a) Baseline recording of the waves before administration of polysulfides or 
sulfide; (b) recording of the wave immediately after administration of polysuflde/sulfide; (c)  
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recording of the waves after reaching baseline again. The delay values are mean±SD 
(n=10). Data were calculated as described elsewhere (42).  
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Figure S14 
 
 
 
 
Figure S14. NO-dependent soluble guanylate cyclase (sGC) activation by SULFI/NO as 
compared to the NO donor Sper/NO and the nitroxyl donor Angeli's salt (AS). 
Concentration-dependent activation of sGC in RFL-6 cells (pre-treated with IBMX) by (A) 1 
µM, 10 µM and 100 µM SULFI/NO, (B) 1 µM 10 µM and 100 µM Angeli's salt, and (C) 10 µM 
and 100 µM Sper/NO (C). Activation of sGC by 1 µM SULFI/NO and 1-10 µM AS occurs in 
the presence of high concentrations of SOD converting HNO into NO. 
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Figure S15 
 
 
 
Figure S15. Profile of nitrite (NO2-) and nitrate (NO3-) formation in incubation mixtures 
of DEA/NO or SNAP with HS-.  (A) Nitrite and nitrate generation from aerated mixtures of 2 
µM DEA/NO with 0 µM, 1 µM, 2 µM and 20 µM Na2S incubated over 60 min at RT in 
phosphate buffer 50 mM pH 7.4. (B) Nitrite and nitrate generation from aerated mixtures of 
100 µM SNAP with 0 µM, 2 µM and 20 µM sulfide (HS-) in 50 mM phosphate buffer pH 7.4.
A
B
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SI Tables 
 
Tab. S1:  Changes in hemodynamic parameters after i.v. bolus administration of NaHS 
(dose range 1.8 - 17.8 µmol/kg). 
 
 Dose (mg/Kg) [µmol/kg]  
 
0 
[0] 
0.1 
[1.8] 
0.2 
[3.6] 
0.5 
[8.9] 
1.0 
[17.8] 
 
 mean SD mean SD mean SD mean SD mean SD n 
Peak blood flow velocity (m/s) 1.19 0.09 0.91 0.14 0.98 0.14 0.94 0.08 0.82 0.20 3 
Resp rate (1/min) 73 12 69 19 62 18 54 4 53 3 3 
Stroke volume (ml) (Doppler) 0.36 0.04 0.30 0.05 0.32 0.05 0.32 0.02 0.31 0.06 3 
Cardiac output (ml/min)a 143 5 115 17 121 12 114 9 100** 10 3 
Ejection fraction (%) 88 1 84 3 87 1 87 3 85 4 3 
Fractional shortening (%) 60 3 57 5 57 2 58 5 56 6 3 
aANOVA p = 0.029 F = 3.934 ; Bonferroni post hoc ** p = 0.03 vs. untreated. 
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Tab. S2: Changes in hemodynamic parameters during continuous i.v. infusion of 
NaHS (2.8 µmoles/kg/min).   
 
aANOVA p = 0.20 F = 4.181; Post Hoc Sidak #p<0.05 vs. 5 min; p<0.05 vs. 60 min  
bANOVA p= 0.012 F = 4.820; Post Hoc Sidak ##p<0.05 vs. 5 min; p<0.05 vs. 60 min 
 Time (min)  
 0 5 10 30 60 120  
 mean SD mean SD mean SD mean SD mean SD mean SD n 
Peak blood flow velocity (m/s) 1.14 0.18 1.18 0.17 1.19 0.17 1.16 0.20 1.17 0.11 1.19 0.09 3 
Resp rate (per min) 78 15 77 20 80 19 84 23 78 17 81 16 3 
Stroke volume (ml) (Doppler) 0.35 0.03 0.38 0.04 0.37 0.03 0.38 0.05 0.38 0.03 0.40 0.03 3 
Cardiac output (ml/min) 128 19 133 12 136 8 140 20 136 6 140 2 3 
% Ejection fractiona 82.0 4.4 77.3 5.0 85.1 0.1 89.9# 2.9 79.1 6.1 79.7 1.7 3 
% Fractional shorteningb 52.5 6.7 48.1 5.4 56.7 0.2 64.5## 5.5 48.9 6.3 48.5 3.2 3 
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Tab. S3:  Changes in hemodynamic parameters after bolus i.v. administration of 
SSNO- (dose range 0.03 - 3 µmol/kg) 
 
Doses (nmol) [µmol/Kg]  
0 
[0] 
10 
[0.03] 
30 
[0.09] 
100 
[0.3] 
300 
[0.9] 
1000 
[3] 
  
mean SD mean SD mean SD mean SD mean SD mean SD n 
Heart rate (per min) 368 19 396 9 396 5 410 58 401 59 415 57 3 
Peak blood flow velocity (m/s) 1.0 0.1 1.0 0.1 1.1 0.2 1.0 0.2 1.1 0.1 1.0 0.1 3 
Resp rate (per min) 71 5 75 2 69 7 72 5 69 9 57 9 3 
Stroke volume (ml) (Doppler) 0.30 0.01 0.31 0.04 0.33 0.05 0.29 0.04 0.31 0.06 0.31 0.05 3 
Cardiac output (ml/min) 112 9 121 11 133 19 117 14 122 6 125 3 3 
% Ejection fraction 83 4.3 87 5.4 83 1.8 84 8.2 86 6.2 86 2.8 3 
% Fractional shortening 51 4.7 59 7.6 53 2.1 57 10.3 56 11.1 61 7.6 3 
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Tab. S4: Changes in cardiovascular hemodynamic parameters during continuous 
infusion of SSNO- (0.16 µmol/kg/min). 
 
 Time (mins) 
 0 5 10 30 60 120  
 mean SD mean SD mean SD mean SD mean SD mean SD n 
Heart rate (per min) 389 34 375 60 338 25 371 48 368 39 375 32 3 
Peak blood flow velocity 
(m/s) 
0.9 0.0 1.0 0.0 0.9 0.1 1.0 0.1 1.1 0.1 1.2 0.2 3 
Resp rate (per min) 66 1 72 6 77 8 74 7 77 6 75 2 3 
Stroke volume (ml) (Doppler) 0.29 0.02 0.29 0.03 0.30 0.03 0.32 0.03 0.35 0.04 0.36 0.03 3 
Cardiac output (ml/min) 111 2 109 8 100 18 119 17 129 17 136 23 3 
% Ejection fraction 82.4 2.0 77.2 4.0 78.5 4.3 83.1 2.7 83.7 4.1 81.4 4.6 3 
% Fractional shortening 53.0 3.8 46.9 4.7 48.3 5.3 53.6 1.6 54.7 4.5 52.5 4.9 3 
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Tab. S5: Changes in cardiovascular hemodynamic parameters during bolus i.v. 
injection of SULFI/NO (dose range 0.03 - 3 µmol/kg) 
 
 
10 mM SULFI/NO stock solution was prepared in 10 mM NaOH/0.9% NaCl. None of the parameter analyzed was significantly 
different from the vehicle control (NaOH dose range 0.03 - 3 µmol/kg) 
aANOVA p=0.014 F=4.652; #Post hoc Sidak p = 0.031 vs. baseline. §T-Test vs. baseline p = 0.02137 
bANOVA p = 0.022 F = 4.066; ##Post hoc Sidak p<0.05 vs. 300 µmol p<0.05 vs. 1000 µmol; §§T-Test vs. baseline p = 0.0406 
n.d. not determined 
 
Doses (nmol) [µmol/Kg] 
 
 
0 
[0] 
10 
[0.03] 
30 
[0.09] 
100 
[0.3] 
300 
[0.9] 
1000 
[3] 
 
 mean SD mean SD mean SD mean SD mean SD mean SD n 
Heart rate (per min) 405.67 23.46 430.00 22.52 431.67 16.50 412.67 33.17 408.33 31.79 417.00 31.32 3 
Peak flow velocity (m/s)a 1.06 0.12 1.11 0.15 1.17 0.12 1.19 0.06 1.39 0.16 1.49# 0.16 3 
Resp rate (per min) 78.33 1.53 82.67 6.43 79.67 10.02 74.67 6.66 78.00 3.61 74.33 8.08 3 
Stroke volume (ml) (Doppler)b 0.33 0.04 0.34 0.06 0.28## 0.03 0.35 0.02 0.40 0.06 0.40§ 0.01 3 
Cardiac output (ml/min) 132.60 21.80 144.76 24.73 120.74 15.48 144.39 4.82 163.94 15.30 167.89 15.44 3 
% Ejection fraction n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d. 3 
% Fractional shortening 54.64 3.03 52.09 4.90 54.72 9.40 54.63 1.26 54.35 6.09 57.40 10.11 3 
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Tab. S6: Changes in cardiovascular hemodynamic parameters during continuous 
infusion of SULFI/NO (0.16 µmol/kg/min) or vehicle control (4.16 µmol NaOH/kg/min). 
 
Time (mins) 
 
0 5 10 30 60 120  
SULFI/NO mean SD mean SD mean SD mean SD mean SD mean SD n 
Blood pressure (mmHg)a 88.3n.s. 8.6 93.8n.s. 7.8 80.4n.s. 6.5 76.0n.s. 11.1 78.2n.s. 8.0 75.4n.s. 10.5 3 
VTI (cm)b 5.20 0.53 5.67 0.21 6.60 0.26 7.33** 0.58 7.43*** 0.32 8.23*** 0.59 3 
Heart rate (per min) 369.0 20.5 392.0 29.5 394.3 32.3 348.3 12.1 349.7 23.2 355.3 38.7 3 
Peak blood flow velocity (m/s)c 1.1 0.1 1.1 0.1 1.3 0.0 1.4* 0.1 1.4** 0.0 1.5*** 0.1 3 
Resp rate (per min) 77.0 12.1 70.3 8.1 71.0 13.0 73.0 14.7 76.7 17.2 75.7 11.0 3 
Stroke volume (ml) (Doppler)d 0.32 0.03 0.35 0.01 0.41 0.02 0.45** 0.04 0.46** 0.02 0.51*** 0.04 3 
Cardiac output (ml/min)e 117.7 6.7 136.6 7.7 160.4 16.3 157.6 18.0 160.3 17.1 179.5* 14.0 3 
Vehicle (NaOH) mean SD mean SD mean SD mean SD mean SD mean SD n 
Blood pressure (mmHg) 87.1 3.7 101.8 27.3 94.9 16.8 80.1 5.2 95.8 12.6 92.8 5.1 3 
VTI (cm) 5.53 0.60 5.30 0.20 5.70 0.26 5.90 0.52 5.67 0.06 5.5 0.46 3 
Heart rate (per min) 386.3 28.7 378.0 44.2 393.7 24.9 381.7 10.1 354.7 11.9 402.7 70.8 3 
Peak blood flow velocity (m/s) 1.1 0.1 1.1 0.1 1.2 0.1 1.2 0.1 1.2 0.0 1.2 0.1 3 
Resp rate (per min) 78.3 11.9 76.7 11.9 74.7 16.2 71.3 5.0 70.7 7.5 75.0 8.5 3 
Stroke volume (ml) (Doppler) 0.34 0.04 0.33 0.01 0.35 0.02 0.36 0.03 0.35 0.00 0.34 0.03 3 
Cardiac output (ml/min) 131.7 19.0 123.0 9.8 137.9 3.3 138.8 14.3 123.7 3.6 137.6 34.0 3 
In order to keep SULFI/NO stable during infusion, a 1 mM SULFI/NO stock solution was prepared in 25 mM NaOH/0.9% NaCl. 
The effects of SULFI/NO infusion were compared to the effects of the vehicle control.  
a 2-way-ANOVA vs. vehicle p = 0.0906 n.s. vs. vehicle; b 2-way ANOVA p<0.0001  **p<0.01 ***p<0.001 vs. vehicle; c 2-way 
ANOVA p = 0.0002 Bonferroni *p<0.05 **p<0.01 ***p<0.001 vs. vehicle; d 2-way ANOVA p = 0.0001 Bonferroni **p<0.01 
***p<0.001 vs. vehicle; 2-way ANOVA p = 0.0138 Bonferroni *p<0.05 vs. vehicle 
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Tab. S7: Identification by ESI-HR mass spectrometry of SULFI/NO and SSNO- as S/N 
hybrid species formed in the reaction of sulfide with DEA/NO or SNAP. The 
corresponding mass spectra are shown in Figure 3.  
   
Assignment 
Panel  
Experimental 
[m/z] 
Theoretical 
[m/z] d [ppm] 
SSNO- a - mass spectrum 93.9427 93.9427 <0.1 
S3-· a - mass spectrum 95.9168 95.9168 <0.1 
SSNO- a - fragmentation 93.9431 93.9427 0.4 
S2-· a - fragmentation 63.9452 63.9447 0.5 
S15SNO- a - 15N labeling 94.9398 94.9397 0.1 
S14SNO- a - 15N labeling 93.9428 93.9427 0.1 
SULFI/NO- b - mass spectrum 140.9617 140.9612 0.5 
HN3S3- b - mass spectrum 138.9154 138.9338 -18.4 
SULFI/NO- b - fragmentation 140.9615 140.9612 0.3 
HSO4- b - fragmentation 96.9606 96.9601 0.5 
HO515N2S- b- 15N labeling 142.9550 142.9552 0.2 
HO514N15NS- b- 15N labeling 141.9579 141.9582 0.3 
HO514N2S-- b- 15N labeling 140.9609 140.9612 0.3 
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